UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 25, 2015 (August 19, 2015)

 

 

MARRONE BIO INNOVATIONS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-36030   20-5137161

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

1540 Drew Avenue, Davis, CA   95618
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (530) 750-2800

(Former name or former address, if changed since last report.)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 1.01. Entry into a Material Definitive Agreement.

On August 20, 2015, Marrone Bio Innovations, Inc. (the “Company”) issued and sold to Ivy Science & Technology Fund, Waddell & Reed Advisors Science & Technology Fund and Ivy Funds VIP Science & Technology (the “Investors”) senior secured promissory notes in the aggregate principal amount of $40,000,000 (the “Notes”) and warrants to purchase up to 4,000,000 shares of common stock, $0.00001 par value per share, of the Company (the “Warrants”) for an aggregate consideration of $40,000,000, pursuant to a purchase agreement, dated August 20, 2015, by and among the Company and the Investors (the “Financing”).

The Notes will bear interest at a rate of 8% per annum payable semi-annually on June 30 or December 31 of each year, commencing on December 31, 2015, with $10 million payable 3 years from the closing, $10 million payable 4 years from the closing, and $20 million due 5 years from the closing. The Notes contain customary covenants, in addition to the obligation to maintain cash and cash equivalents of at least $15 million. The Notes provide for various events of default, including, among others, default in payment of principal or interest, breach of any representation or warranty by the Company or any subsidiary under any agreement or document delivered in connection with the Notes (the “Loan Documents”), a continued breach of any other condition or obligation under any Loan Document, certain bankruptcy, liquidation, reorganization or change of control events, the acquisition by any person or persons acting as group, other than the Investors, of beneficial ownership of 40% or more of the outstanding voting stock of the Company and certain events in which Dr. Pamela Marrone ceases to serve as the Company’s chief executive officer.

The Notes are secured by substantially all the Company’s personal property assets, as described in the Security Agreement entered into among the Company, Ivy Investment Management Company, as agent for the Investors (the “Agent”), and the Investors on August 20, 2015 (the “Security Agreement”). The Agent, acting behalf of the Investors, shall be entitled to have a first priority lien on the Company’s intellectual property assets, pursuant to intercreditor arrangements with certain of the Company’s existing lenders as represented by Gordon Snyder, an individual, as administrative agent and collateral agent for such lenders (the “Snyder Agent”).

The Warrants are immediately exercisable at an exercise price of $1.91 per share (subject to adjustments) and may be exercised at a holder’s option at any time on or before August 20, 2023. The Warrants provide that the Company shall not effect any exercise of a Warrant, and a holder shall not have the right to exercise any portion of a Warrant, to the extent that after giving effect to such issuance after exercise, the holder (together with the holder’s affiliates, and any other person acting as a group together with the holder or any of the holder’s affiliates), would beneficially own in excess of 19.99% of the number of shares of common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon exercise of the Warrant. In addition, the Company will redeem the Warrants upon the occurrence of any Fundamental Transaction (as defined in the Warrants).

The Notes and the Warrants were offered and sold to “accredited investors” (as defined in Rule 501(a) of Regulation D) pursuant to an exemption from the registration requirements under Section 4(2) of the Securities Act of 1933 (the “Securities Act”) and Rule 506 of Regulation D promulgated thereunder.

In connection with the Financing, on August 19, 2015, the Company entered into an omnibus amendment to loan agreement (the “Amendment”) with the Snyder Agent. The Amendment amends the Loan Agreement dated as of October 2, 2012 (as amended by that certain Amendment and Consent dated as of April 10, 2013), by and between the Company, the lenders party thereto, and the Snyder Agent as administrative agent and collateral agent for such lenders (the “Snyder Loan Agreement”), relating to approximately $12.6 million of outstanding indebtedness, including accrued interest. Under the Snyder Loan Agreement, as amended by the Amendment, interest on loans will accrue at a rate of 12% per annum until September 1, 2015, and thereafter will accrue at a rate of 18% per annum, and the Company will be permitted to prepay at any time the outstanding indebtedness under the Snyder Loan Agreement without penalty.

The foregoing summary of the terms of the Notes, Warrants, Security Agreement, and Amendment do not purport to be complete and are qualified in their entirety by the Notes, Warrants, Security Agreement, and Amendment. The form of Note is attached hereto as Exhibit 4.1, the form of Warrant is attached hereto as Exhibit 4.2, the Security Agreement is attached hereto as Exhibit 10.1, and the Amendment is attached hereto as Exhibit 10.2, and all of such Exhibits are incorporated herein by reference.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information provided in Item 1.01 is hereby incorporated by reference to this Item 2.03.

Item 3.02. Unregistered Sales of Equity Securities.

The information provided in Item 1.01 is hereby incorporated by reference to this Item 3.02.


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On August 20, 2015, the Company entered into a separation agreement (the “Separation Agreement”) with James Iademarco, President and Chief Operating Officer of the Company, whereby Mr. Iademarco is resigning effective as of August 31, 2015, but has agreed to remain available to advise the Company in a consulting capacity for an additional period of up to 90 days to assist with the transition of various pending matters. Pursuant to the Separation Agreement, Mr. Iademarco will be entitled to receive, among other things, an amount equal to one-twelfth of his base salary on or before the 15th day of each of the twelve months following August 31, 2015 and certain premium payments for health and vision insurance coverage, in partial consideration for Mr. Iademarco granting the Company a general release of liability and claims.

The description of the Separation Agreement herein is limited in its entirety by the terms of the Separation Agreement filed as Exhibit 10.3 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 8.01 Other Events

On August 21, 2015 the Company issued a press release announcing the completion of the sale of the Notes and Warrants, the resignation of Mr. Iademarco and the receipt of a notice of late filing from NASDAQ. A copy of the press release is attached hereto as Exhibit 99.1, which is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Exhibit 99.1 shall not be incorporated by reference into any filing under the Securities or Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

Exhibit

No.

  

Description

  4.1    Form of Note
  4.2    Form of Warrant
10.1    Security Agreement dated as of August 20, 2015 by and among Marrone Bio Innovations, Inc. and the counterparties thereto
10.2    Omnibus Amendment to Loan Agreement dated as of August 19, 2015 by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent
10.3*    Separation Agreement, dated as of August 20, 2015 by and between Marrone Bio Innovations, Inc. and James Iademarco
99.1    Press release issued on August 21, 2015 by Marrone Bio Innovations, Inc.

 

* Denotes management contract, compensatory plan or arrangement.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MARRONE BIO INNOVATIONS, INC.
Dated: August 25, 2015     By:  

/s/ Linda V. Moore

      Linda V. Moore
      Vice President, General Counsel and Secretary


EXHIBIT INDEX

 

Exhibit

No.

  

Description

  4.1    Form of Note
  4.2    Form of Warrant
10.1   

Security Agreement dated as of August 20, 2015 by and among Marrone Bio Innovations, Inc. and the counterparties thereto

10.2    Omnibus Amendment to Loan Agreement dated as of August 19, 2015 by and between Marrone Bio Innovations, Inc. and Gordon Snyder, as agent
10.3*    Separation Agreement, dated as of August 20, 2015 by and between Marrone Bio Innovations, Inc. and James Iademarco
99.1    Press release issued on August 21, 2015 by Marrone Bio Innovations, Inc.

 

* Denotes management contract, compensatory plan or arrangement.

Exhibit 4.1

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE BORROWER THAT SUCH SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING SUCH SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

SENIOR SECURED PROMISSORY NOTE

 

$[        ]   Dated: August 20, 2015

FOR VALUE RECEIVED, the undersigned, MARRONE BIO INNOVATIONS, INC. (the “Borrower”), HEREBY UNCONDITIONALLY PROMISES TO PAY to the order of [        ] (the “Lender”), the principal sum of [        DOLLARS ($        )] 1 , in installments as set forth in the payment schedule below and with the last such installment to be due and payable on August     , 2020 2 (the “Maturity Date”) and in the amount necessary to repay in full the unpaid principal balance hereof. This Senior Secured Promissory Note (this “Note”) is issued by the Borrower to the Lender pursuant to that certain Purchase Agreement, dated as of August [    ], 2015, by and between the Borrower, the Lender, the other investors party thereto (together with Lender, the “Lenders”) (the “Purchase Agreement”). Terms used but not defined herein shall have the meaning set forth in Annex I.

 

  1. Payment Schedule

 

PAYMENT SCHEDULE

Payment Date

  

Amount Due

August     , 2018 3

   $[            ] 4

August     , 2019 5

   $[            ] 6

Maturity Date

   $[            ] 7

 

1   Allocate among the Lenders.
2   5 years from date of Note
3   3 years from date of Note
4   25%
5   4 years from date of Note
6   25%
7   50%

 

1.


  2. Interest

The Borrower further promises to pay interest on the outstanding principal amount of this Note from the date hereof until maturity at the Maturity Date, in arrears, semi-annually, on June 30 or December 31 of each year, commencing on December 31, 2015, and at maturity at the Maturity Date, at the rate of 8% per annum. In the event that any amount of principal or interest or any other amount payable hereunder, is not paid in full when due (whether at stated maturity, by acceleration or otherwise), the Borrower agrees to pay interest on such unpaid principal or other amount, from the date such amount becomes due until the date such amount is paid in full, payable on demand, at a rate of 10% per annum. All computations of interest shall be made on the basis of a year of 365 or 366 days, as the case may be, for the actual number of days (including the first day but excluding the last day) occurring in the period for which such interest is payable.

 

  3. Payment Terms

All payments hereunder shall be made in lawful money of the United States of America and in same day or immediately available funds, to the Lender, in accordance with the Lender’s payment instructions.

Whenever any payment hereunder shall be stated to be due, or whenever any interest payment date or any other date specified hereunder would otherwise occur, on a day other than a Business Day (as defined below), then such payment shall be made, and such interest payment date or other date shall occur, on the next succeeding Business Day, and such extension of time shall in such case be included in the computation of payment of interest hereunder. As used herein, “Business Day” means a day (i) other than Saturday or Sunday, and (ii) on which commercial banks are open for business in California and Kansas.

In no event shall the Borrower be obligated to pay the Lender interest, charges or fees at a rate in excess of the highest rate permitted by applicable law which a court of competent jurisdiction shall, in a final determination, deem applicable hereto. In the event that such a court determines that the Lenders have charged or received interest hereunder in excess of the highest applicable rate, the rate in effect hereunder shall automatically be reduced to the maximum rate permitted by applicable law and the Lenders shall, at their option (i) promptly refund to the Borrower any interest received by the Lenders in excess of the maximum lawful rate or (ii) apply such excess to the principal balance of this Note on a pro rata basis. It is the intent hereof that the Borrower not pay or contract to pay, and that the Lenders not receive or contract to receive, directly or indirectly in any manner whatsoever, interest in excess of that which may be paid by the Borrower under applicable law.

 

2.


  4. Prepayment

The Borrower may upon prior notice to the Lender prepay the outstanding amount hereof in whole or in part at any time, without premium or penalty. Together with any such prepayment the Borrower shall pay accrued interest on the principal amount prepaid. Any partial prepayment shall be applied to the installments of principal hereof in reverse order of maturity. No such prepaid amount may be reborrowed hereunder.

 

  5. Affirmative Covenants

So long as any amount payable by the Borrower hereunder shall remain unpaid:

(i) Preservation of Existence, Etc. The Borrower will, and will cause of its Subsidiaries to, maintain and preserve its legal existence, its rights to transact business and all other rights, franchises and privileges necessary or desirable in the normal course of its business and operations and the ownership of its properties.

(ii) Payment of Taxes . The Borrower will, and will cause of its Subsidiaries to, pay and discharge all taxes, fees, assessments and governmental charges or levies imposed upon it or upon its properties or assets prior to the date on which penalties attach thereto, and all lawful claims for labor, materials and supplies which, if unpaid, might become a Lien upon any properties or assets of the Borrower or such Subsidiary, except to the extent such taxes, fees, assessments or governmental charges or levies, or such claims, are being contested in good faith by appropriate proceedings and are adequately reserved against in accordance with GAAP; provided that the failure to make any such payments shall not constitute a breach of this covenant unless the aggregate amount of such payments could reasonably be expected to exceed $200,000.

(iii) Maintenance of Insurance . The Borrower will, and will cause of its Subsidiaries to, (i) carry and maintain in full force and effect insurance in such amounts, with such deductibles and covering such risks as is customarily carried by companies engaged in the same or similar businesses and owning similar properties in the localities where the Borrower or such Subsidiary operates as determined by the Borrower in its sole discretion (with appropriate endorsements naming the Agent as lender’s loss payee (and mortgagee, as applicable) on all policies for property hazard insurance and as additional insured on all policies for liability insurance, and if requested by the Agent, copies of such insurance policies and (ii) if requested by the Agent in writing, promptly provide the Agent with such evidence as it reasonably requests to demonstrate compliance with this Section 5(iii).

(iv) Keeping of Records and Books of Account . The Borrower will, and will cause of its Subsidiaries to, keep proper books, records and accounts (which shall be true and complete in all material respects) as may be required or as may be necessary to permit the preparation of financial statements in accordance with GAAP and in compliance with the regulations of any governmental authority having jurisdiction over it or any of its properties.

(v) Inspection Rights . Upon ten Business Days’ prior written notice, the Borrower will, and will cause of its Subsidiaries to, at any reasonable time during normal business hours and from time to time, permit the Lender or any of its agents or representatives to visit and inspect its properties; inspect, audit and make extracts from its books, records and files, including, but not limited to, management letters prepared by independent accountants; and discuss with its principal officers, and its independent accountants, its business, assets, liabilities, financial condition, results of operations and business prospects.

 

3.


(vi) Compliance with Laws, Etc . The Borrower will, and will cause of its Subsidiaries to, comply in all material respects with the requirements of all applicable material laws, rules, regulations and orders of any governmental agency or authority, including all Environmental Laws and ERISA; provided, however, that the Borrower may remain delinquent in its periodic reporting obligations under the Exchange Act until the completion of the Restatement (as defined in the Purchase Agreement).

(vii) Maintenance of Properties, Etc . The Borrower will and will cause of its Subsidiaries to, maintain and preserve all of its material properties necessary or useful in the proper conduct of its business in good working order and condition in accordance with the general practice of other Persons of similar character and size, ordinary wear and tear excepted.

(viii) Licenses . The Borrower will, and will cause of its Subsidiaries to, obtain and maintain all material licenses, authorizations, consents, filings, exemptions, registrations and other governmental approvals of any governmental agency or authority necessary for the operation and conduct of its business.

(ix) Minimum Cash Balance . The Borrower shall maintain a balance consisting of cash and cash equivalents of at least $15,000,000.

(x) Financial Information . Commencing at such time as the Borrower is no longer required to file periodic reports under the Exchange Act, the Borrower shall deliver to the Lender:

(a) Annual Financial Statements . As soon as practicable and in any event within ninety (90) days after the end of each fiscal year, an audited consolidated balance sheet of the Borrower and its Subsidiaries as of the close of such fiscal year and audited consolidated statements of income, retained earnings and cash flows including the notes thereto, all in reasonable detail setting forth in comparative form the corresponding figures as of the end of and for the preceding fiscal year and prepared in accordance with GAAP and, if applicable, containing disclosure of the effect on the financial position or results of operations of any change in the application of accounting principles and practices during the year. Such annual financial statements shall be audited by an independent certified public accounting firm of recognized national standing, and accompanied by a report and opinion thereon by such certified public accountants prepared in accordance with generally accepted auditing standards that is not subject to any material qualification as to the scope of such audit or with respect to accounting principles followed by the Borrower or any of its Subsidiaries not in accordance with GAAP.

(b) Quarterly Financial Statements . As soon as practicable and in any event within forty-five (45) days after the end of the first three fiscal quarters of each fiscal year, an unaudited consolidated balance sheet of the Borrower and its

 

4.


Subsidiaries as of the close of such fiscal quarter and unaudited consolidated statements of income, retained earnings and cash flows and a report containing management’s discussion and analysis of such financial statements for the fiscal quarter then ended and that portion of the fiscal year then ended, including the notes thereto, all in reasonable detail setting forth in comparative form the corresponding figures as of the end of and for the corresponding period in the preceding fiscal year and prepared by the Borrower in accordance with GAAP and, if applicable, containing disclosure of the effect on the financial position or results of operations of any change in the application of accounting principles and practices during the period, and certified by the chief financial officer of the Borrower to present fairly in all material respects the financial condition of the Borrower and its Subsidiaries on a consolidated basis as of their respective dates and the results of operations of the Borrower and its Subsidiaries for the respective periods then ended, subject to normal year-end adjustments and the absence of footnotes.

(xii) Certificates; Other Reports . The Borrower will deliver to the Lender:

(c) promptly upon receipt thereof, copies of all reports, if any, submitted to the Borrower, any Subsidiary thereof or any of their respective boards of directors by their respective independent public accountants in connection with their auditing function, including, without limitation, any management report and any management responses thereto;

(d) promptly after the assertion or occurrence thereof, notice of any action or proceeding against or of any noncompliance by the Borrower or any Subsidiary thereof with any Environmental Law that could reasonably be expected to have a Material Adverse Effect;

(e) promptly after the same are available, copies of each annual report, proxy or financial statement or other report or communication sent to the stockholders of the Borrower, and copies of all annual, regular, periodic and special reports and registration statements which the Borrower may file or be required to file with the SEC under Section 13 or 15(d) of the Exchange Act, or with any national securities exchange, and in any case not otherwise required to be delivered to the Lender pursuant hereto;

(f) promptly, and in any event within five (5) Business Days after receipt thereof by the Borrower or any Subsidiary thereof, copies of each notice or other correspondence received from the SEC (or comparable agency in any applicable non-U.S. jurisdiction) concerning any investigation or possible investigation or other inquiry by such agency regarding financial or other operational results of the Borrower or any Subsidiary thereof; and

(g) such other information regarding the operations, business affairs and financial condition of the Borrower or any Subsidiary thereof as the Lender may reasonably request.

 

5.


(xiii) Notice of Litigation and Other Matters

(a) The Borrower will deliver to the Lender prompt (but in no event later than ten (10) days after any officer of the Borrower obtains knowledge thereof) written notice of:

 

  (i) the commencement of all proceedings and investigations by or before any governmental authority and all actions and proceedings in any court or before any arbitrator against or involving any the Borrower or any Subsidiary thereof or any of their respective properties, assets or businesses that, if adversely determined, could reasonably be expected to have a Material Adverse Effect;

 

  (ii) any notice of any violation received by the Borrower or any Subsidiary thereof from any governmental authority including, without limitation, any notice of violation of Environmental Laws which in any such case could reasonably be expected to have a Material Adverse Effect; and

 

  (iii) (x) any Event of Default or (y) any event or circumstance which constitutes or which with the passage of time or giving of notice or both would constitute an Event of Default.

(xiv) Additional Subsidiaries . The Borrower will notify the Agent of the creation or acquisition of any new domestic Subsidiary and promptly thereafter (and in any event within thirty (30) days after such creation or acquisition), cause such Person to (i) become a Subsidiary Guarantor by delivering to the Agent a duly executed Subsidiary Guaranty Agreement (or supplement thereto) or such other document as the Agent shall deem appropriate for such purpose, (ii) grant a security interest in all Collateral (subject to the exceptions specified in the Security Agreement) owned by such Subsidiary by delivering to the Agent a duly executed supplement to each Security Document or such other document as the Agent shall deem appropriate for such purpose and comply with the terms of each Security Document, (iii) deliver to the Agent such original Capital Stock or other certificates and stock or other transfer powers evidencing the Capital Stock of such Person, (iv) deliver to the Agent such updated Schedules to the Loan Documents as requested by the Agent with respect to such Person, and (v) deliver to the Agent such other documents as may be reasonably requested by the Agent, all in form, content and scope reasonably satisfactory to the Agent.

 

  6. Negative Covenants

So long as any amount payable by the Borrower hereunder shall remain unpaid neither the Borrower nor any of its Subsidiaries will:

(i) Indebtedness . Create, incur, assume or otherwise become liable for or suffer to exist any Indebtedness, other than Permitted Indebtedness.

 

6.


(ii) Fundamental Changes . Merge, consolidate or enter into any similar combination with any other Person or liquidate, wind-up or dissolve itself (or suffer any liquidation or dissolution) except:

(b) (i) any wholly-owned Subsidiary of the Borrower may be merged, amalgamated or consolidated with or into the Borrower ( provided that the Borrower shall be the continuing or surviving entity), (ii) any wholly-owned Subsidiary of the Borrower may be merged, amalgamated or consolidated with or into any Subsidiary Guarantor ( provided that the Subsidiary Guarantor shall be the continuing or surviving entity or simultaneously with such transaction, the continuing or surviving entity shall become a Subsidiary Guarantor), and (iii) any wholly-owned Subsidiary of the Borrower may be merged, amalgamated or consolidated with or into any other wholly-owned Subsidiary that is not a Subsidiary Guarantor; provided that the surviving entity is a Subsidiary Guarantor;

(c) any Subsidiary may dispose of all or substantially all of its assets (upon voluntary liquidation, dissolution, winding up or otherwise) to the Borrower or any other Subsidiary; provided that, with respect to any such disposition by any Subsidiary that is not a Subsidiary Guarantor, the consideration for such disposition shall not exceed the fair value of such assets;

(d) dispositions permitted by Section 6(v) ; and

(e) any Person may merge into the Borrower or any of its wholly-owned Subsidiaries in connection with a Permitted Acquisition; provided that (i) in the case of a merger involving the Borrower or a Subsidiary Guarantor, the continuing or surviving Person shall be the Borrower or such Subsidiary Guarantor and (ii) the continuing or surviving Person shall be the Borrower or a wholly-owned Subsidiary of the Borrower.

(iii) Investments . Purchase, own, invest in or otherwise acquire (in one transaction or a series of transactions), directly or indirectly, any Capital Stock, interests in any partnership or joint venture (including, without limitation, the creation or capitalization of any Subsidiary), evidence of Indebtedness or other obligation or security, substantially all or a portion of the business or assets of any other Person or any other investment or interest whatsoever in any other Person, or make or permit to exist, directly or indirectly, any loans, advances or extensions of credit to, or any investment in cash or by delivery of Property in, any Person (all the foregoing, “ Investments ”) except:

(a) Investments existing on the Closing Date in Subsidiaries existing on the Closing Date;

(b) Investments in cash and cash equivalents;

(c) Investments by the Borrower or any of its Subsidiaries in the form of capital expenditures permitted pursuant to this Agreement;

(d) deposits made in the ordinary course of business to secure the performance of leases or other obligations;

(e) purchases of assets in the ordinary course of business;

 

7.


(f) Investments by the Borrower or any Subsidiary thereof in the form of Permitted Acquisitions to the extent that any Person or property acquired in such acquisition becomes a part of the Borrower or a Subsidiary Guarantor or becomes a Subsidiary Guarantor in the manner contemplated by Section 5(xiii);

(g) Investments in the form of loans and advances to officers, directors and employees in the ordinary course of business in an aggregate amount not to exceed at any time outstanding $150,000 (determined without regard to any write-downs or write-offs of such loans or advances);

(h) Investments not otherwise permitted pursuant to this Section in an aggregate amount not to exceed $250,000 at any time outstanding; provided that, immediately before and immediately after giving pro forma effect to any such Investments, no Default or Event of Default shall have occurred and be continuing.

(iv) Liens . Create, incur, assume or suffer to exist, any Lien on or with respect to any of its property, whether now owned or hereafter acquired, except the following Liens (“ Permitted Liens ”):

(i) Liens created pursuant to the Loan Documents;

(j) Liens in existence on the Closing Date and described on Schedule 6(iv) , including Liens incurred in connection with any refinancing, refunding, renewal or extension of Indebtedness; provided that the scope of any such Lien shall not be increased, or otherwise expanded, to cover any additional property or type of asset, as applicable, beyond that in existence on the Closing Date, except for products and proceeds of the foregoing;

(k) Liens for taxes, assessments and other governmental charges or levies (excluding any Lien imposed pursuant to any of the provisions of ERISA or Environmental Laws) (i) not yet due or as to which the period of grace (not to exceed thirty (30) days), if any, related thereto has not expired or (ii) which are being contested in good faith and by appropriate proceedings if adequate reserves are maintained to the extent required by GAAP;

(l) the claims of materialmen, mechanics, carriers, warehousemen, processors or landlords for labor, materials, supplies or rentals incurred in the ordinary course of business, which (i) if overdue, no action to Borrower’s knowledge has been taken to enforce such Liens and such Liens are being contested in good faith and by appropriate proceedings if adequate reserves are maintained to the extent required by GAAP and (ii) do not, individually or in the aggregate, materially impair the use thereof in the operation of the business of the Borrower or any of its Subsidiaries;

(m) Liens consisting of deposits or pledges made in the ordinary course of business in connection with, or to secure payment of, obligations under workers’ compensation, unemployment insurance and other types of social security or

 

8.


similar legislation, or to secure the performance of bids, trade contracts and leases (other than Indebtedness), statutory obligations, surety bonds (other than bonds related to judgments or litigation), performance bonds and other obligations of a like nature incurred in the ordinary course of business, in each case, so long as no foreclosure sale or similar proceeding has been commenced with respect to any portion of the Collateral on account thereof;

(n) Purported Liens evidenced by the filing of precautionary UCC financing statements relating solely to personal property leased pursuant to operating leases entered into in the ordinary course of business of the Borrower and its Subsidiaries;

(o) Liens securing judgments for the payment of money not constituting an Event of Default or securing appeal or other surety bonds relating to such judgments;

(p) (i) Liens of a collecting bank arising in the ordinary course of business under Section 4-210 of the Uniform Commercial Code in effect in the relevant jurisdiction and (ii) Liens of any depositary bank in connection with statutory, common law and contractual rights of set-off and recoupment with respect to any deposit account of any Borrower or any Subsidiary thereof;

(q) (i) contractual or statutory Liens of landlords to the extent relating to the property and assets relating to any lease agreements with such landlord, and (ii) contractual Liens of suppliers (including sellers of goods) or customers granted in the ordinary course of business to the extent limited to the property or assets relating to such contract;

(r) any interest or title of a licensor, sublicensor, lessor or sublessor with respect to any assets under any license or lease agreement entered into in the ordinary course of business which do not (i) interfere in any material respect with the business of the Borrower or its Subsidiaries or materially detract from the value of the relevant assets of the Borrower or its Subsidiaries or (ii) secure any Indebtedness;

(s) Liens securing Purchase Money Indebtedness;

(t) Liens securing Subordinated Debt, pursuant to a subordination agreement in form and substance satisfactory to the Agent;

(u) Liens existing on such property at the time of its acquisition in connection with a Permitted Acquisition, provided that the Lien is confined solely to the property so acquired and improvements thereon;

(v) Liens not otherwise permitted hereunder on assets other than the Collateral securing Indebtedness or other obligations in the aggregate principal amount not to exceed $250,000 at any time outstanding.

 

9.


(v) Asset Dispositions . Make any disposition of any or all of the assets (including, without limitation, any Capital Stock owned thereby) whether by sale, lease, transfer or otherwise, except the sale of inventory in the ordinary course of business and the sale of obsolete, worn-out or surplus assets no longer used or usable in the business of the Borrower or any of its Subsidiaries.

(vi) Restricted Payments . Declare or pay any dividend on, or make any payment or other distribution on account of, or purchase, redeem, retire or otherwise acquire (directly or indirectly), or set apart assets for a sinking or other analogous fund for the purchase, redemption, retirement or other acquisition of, any class of Capital Stock of any the Borrower or any Subsidiary thereof, or make any distribution of cash, property or assets to the holders of shares of any Capital Stock of the Borrower or any Subsidiary thereof (all of the foregoing, the “ Restricted Payments ”) provided that:

(a) the Borrower or any Subsidiary thereof may pay dividends in shares of its own Capital Stock; and

(b) any Subsidiary of the Borrower may pay cash dividends to the Borrower.

(vii) Line of Business . Engage in any business other than the business conducted by the Borrower and its Subsidiaries as of the Closing Date and business activities reasonably related or ancillary thereto or that are reasonable extensions thereof.

(viii) Use of Proceeds . Use any part of the proceeds of any of the Loans for purchasing or carrying margin stock or for any purpose which violates, or which would be inconsistent with, the provisions of Regulation T, U or X of such Board of Governors.

(ix) Rule 17a-6 . Take any action, or fail to take any action, that could cause any Lender to fail to satisfy the safe harbor provisions of Rule 17a-6 under the Investment Company Act of 1940, as amended.

 

  7. Events of Default

The occurrence of any of the following shall constitute an “Event of Default” under this Note:

(i) the failure to make any payment of principal, interest (to the extent not added to the principal as provided herein) or any other amount payable hereunder when due under this Note, and the continuation of such failure for two (2) Business Days;

(ii) Any representation or warranty by the Borrower or any Subsidiary under any Loan Document shall prove to have been incorrect in any material respect when made or deemed made;

(iii) the breach of any other condition or obligation under this Note or any other Loan Document and the continuation of such breach for thirty (30) days after notice thereof from the Agent or knowledge thereof by Borrower;

 

10.


(iv) the filing of a petition by or against the Borrower or any Subsidiary under any provision of the Bankruptcy Reform Act, Title 11 of the United States Code, as amended or recodified from time to time (the “Bankruptcy Code”), or under any similar law relating to bankruptcy, insolvency or other relief for debtors (provided, in the case of an involuntary petition, that such the filing is not dismissed, removed or stayed within thirty (30) days of the institution thereof); or appointment of a receiver, trustee, custodian or liquidator of or for all or any part of the assets or property of the Borrower; or the insolvency of the Borrower; or the making of a general assignment for the benefit of creditors by the Borrower;

(v) the Borrower or any Subsidiary shall (i) liquidate, wind-up or dissolve (or suffer any liquidation, wind-up or dissolution), (ii) suspend its operations other than in the ordinary course of business, or (iii) take any action to authorize any of the actions or events set forth above in paragraph 5;

(vi) (i) the Borrower, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Borrower with or into another Person (but excluding a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Borrower), (ii) the Borrower, directly or indirectly, effects any sale, assignment, transfer or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Borrower or another Person) is completed pursuant to which holders of common stock of the Borrower are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding common stock of the Borrower or (iv) the Borrower, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of the common stock of the Borrower or any compulsory share exchange pursuant to which the common stock of the Borrower is effectively converted into or exchanged for other securities, cash or property;

(vii) any event of default under the Security Agreement (as defined below) shall have occurred and be continuing; or the Security Agreement or any of the other documents relating to the Collateral after delivery thereof shall for any reason be revoked or invalidated, or otherwise cease to be in full force and effect, or the Borrower or any other Person shall contest in any manner the validity or enforceability thereof, or the Borrower or any other Person shall deny that it has any further liability or obligation thereunder; or the Security Agreement or any of the other documents relating to the Collateral for any reason, except to the extent permitted by the terms thereof, shall cease to create a valid and perfected lien in any of the Collateral purported to be covered thereby;

(viii) there is under any agreement to which Borrower or any Subsidiary is a party with a third party or parties any default resulting in a right by such third party or parties, whether or not exercised, to accelerate the maturity of any Indebtedness in an amount individually or in the aggregate in excess of Five Million Dollars ($5,000,000);

(ix) one or more final judgments, orders, or decrees for the payment of money in an amount, individually or in the aggregate, of at least Five Million Dollars ($5,000,000) (not covered by independent third-party insurance as to which liability has been accepted by such insurance carrier) shall be rendered against Borrower or any Subsidiary and the same are not, within thirty (30) days after the entry thereof, discharged or execution thereof stayed or bonded pending appeal, or such judgments are not discharged prior to the expiration of any such stay;

 

11.


(x) the acquisition by any Person, or two or more Persons acting as a “group” (other than the Lender and any Person with whom the Lender is acting in a group or to whom the Lender has directly or indirectly transferred any of the shares of the Borrower of which the Lender has now or becomes entitled to acquire “beneficial ownership”, and the affiliates of the Lender and such other Persons) (as such terms are defined in Rules 13d-5 13d-3 of the Securities and Exchange Commission under the Securities Exchange Act of 1934) beneficial ownership of 40% or more of the outstanding shares of voting stock of the Borrower; or

(xi) the 90th day following the date of a Key Person Event unless, on or prior to such 90th day, the Board appoints an individual reasonably acceptable to Lender as the chief executive officer of the Borrower.

 

  8. Remedies and Enforcement

Upon the occurrence and continuance of any Event of Default, the Agent, at its option, may (i) by notice to the Borrower, declare the unpaid principal amount of this Note, all interest accrued and unpaid hereon and all other amounts payable hereunder to be immediately due and payable, whereupon the unpaid principal amount of this Note, all such interest and all such other amounts shall become immediately due and payable, without presentment, demand, protest or further notice of any kind, provided that upon the occurrence of an actual or deemed entry of an order for relief with respect to the Borrower under the Bankruptcy Code, the result which would otherwise occur only upon giving of notice by the Agent to the Borrower as specified above shall occur automatically, without the giving of any such notice; and (ii) whether or not the actions referred to in clause (i) have been taken, exercise any or all of the Agent’s rights and remedies under the Security Agreement and proceed to enforce all other rights and remedies available to the Agent under applicable law.

The Borrower agrees to pay on demand all the losses, costs, and expenses (including, without limitation, attorneys’ fees and disbursements) which the Agent incurs in connection with enforcement or attempted enforcement of this Note, or the protection or preservation of the Lender’s rights under this Note, whether by judicial proceedings or otherwise. Such costs and expenses include, without limitation, those incurred in connection with any workout or refinancing, or any bankruptcy, insolvency, liquidation or similar proceedings.

The Borrower hereby waives diligence, demand, presentment, protest or further notice of any kind.

 

  9. Miscellaneous

Time is of the essence for the performance of each and every obligation under this Note.

The Borrower agrees to make all payments under this Note without setoff or deduction and regardless of any counterclaim or defense.

 

12.


No single or partial exercise of any power under this Note shall preclude any other or further exercise of such power or exercise of any other power. No delay or omission on the part of the Agent in exercising any right under this Note shall operate as a waiver of such right or any other right hereunder.

This Note shall be binding on the Borrower and its successors and assigns, and shall be binding upon and inure to the benefit of the Lender, any future holder of this Note and their respective successors and assigns.

Except as otherwise provided herein or in any other Loan Document, (i) no amendment to any provision of this Note or any of the other Loan Documents shall in any event be effective unless the same shall be in writing and signed by the Borrower and the Lender; and (ii) no waiver of any provision of this Note or any other Loan Document, or consent to any departure by the Borrower or other party therefrom, shall in any event be effective unless the same shall be in writing and signed by the Borrower and the Lender.

The Borrower will maintain a register in which it will record the initial ownership of this Note and any changes in ownership of this Note which occur as permitted by and in compliance with the terms hereof.

The Borrower shall not have the right to assign its rights and obligations hereunder or any interest herein or therein without the prior written consent of the Lender. The Lender may sell, assign, transfer or grant participations in all or any portion of the Lender’s rights and obligations hereunder. In the event of any such assignment, upon notice thereof to the Borrower, the assignee shall be deemed the “Lender” for all purposes of this Note and any other documents and instruments relating hereto with respect to the rights and obligations assigned to it. The Borrower agrees that in connection with any such grant or assignment, the Lender may deliver to the prospective participant or assignee financial statements and other relevant information relating to the Borrower and its subsidiaries.

All notices and other communications provided for hereunder shall, unless otherwise stated herein, be in writing (including by facsimile) and mailed (by certified or registered mail), sent or delivered (i) if to the Lender,             , attn.             , fax (        )         -        ; and (ii) if to the Borrower, at or to its address or facsimile number set forth below its name on the signature page hereof, or at or to such other address or facsimile number as such party shall have designated in a written notice to the other party. All such notices and communications shall be effective (i) if delivered by hand, sent by certified or registered mail or sent by an overnight courier service, when received; and (ii) if sent by facsimile transmission, when sent.

This Note is secured by certain collateral (the “Collateral”) more specifically described in the Security Agreement of even date herewith between the Borrower and Ivy Investment Management Corp., a Delaware corporation, as agent for the Lenders (the “Agent”) (the “Security Agreement”).

THIS NOTE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH CALIFORNIA LAW WITHOUT GIVING EFFECT TO ANY

 

13.


CHOICE OF LAW RULE THAT WOULD CAUSE THE APPLICATION OF THE LAWS OF ANY JURISDICTION OTHER THAN THE INTERNAL LAWS OF THE STATE OF CALIFORNIA TO THE RIGHTS AND DUTIES OF THE PARTIES.

The Borrower hereby (i) submits to the non-exclusive jurisdiction of the courts of the State of California and the Federal courts of the United States sitting in San Francisco, California for the purpose of any action or proceeding arising out of or relating to this Note and any other documents and instruments relating hereto, (ii) agrees that all claims in respect of any such action or proceeding may be heard and determined in such courts, (iii) irrevocably waives (to the extent permitted by applicable law) any objection which it now or hereafter may have to the laying of venue of any such action or proceeding brought in any of the foregoing courts, and any objection on the ground that any such action or proceeding in any such court has been brought in an inconvenient forum and (iv) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner permitted by law.

THE BORROWER AND, BY ITS ACCEPTANCE HEREOF, THE LENDER, HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO THIS NOTE. IN THE EVENT ANY LEGAL PROCEEDING IS FILED IN A COURT OF THE STATE OF CALIFORNIA (THE “COURT”) BY OR AGAINST ANY PARTY IN CONNECTION WITH ANY CONTROVERSY, DISPUTE OR CLAIM DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS NOTE OR THE TRANSACTIONS CONTEMPLATED HEREBY (EACH, A “CLAIM”) AND THE WAIVER SET FORTH IN THE PRECEEDING PARAGRAPH IS NOT ENFORCEABLE IN SUCH ACTION OR PROCEEDING, THE BORROWOR HEREBY AGREES, AND THE LENDER BY ITS ACCEPTANCE HEREOF HEREBY AGREES, AS FOLLOWS:

(1) WITH THE EXCEPTION OF THE MATTERS SPECIFIED IN SUBPARAGRAPH 2 BELOW, ANY CLAIM WILL BE RESOLVED BY A GENERAL REFERENCE PROCEEDING IN ACCORDANCE WITH THE PROVISIONS OF CALIFORNIA CODE OF CIVIL PROCEDURE SECTIONS 638 THROUGH 645.1.

(2) THE FOLLOWING MATTERS SHALL NOT BE SUBJECT TO A REFERENCE PROCEEDING: (A) NON-JUDICIAL FORECLOSURE OF ANY SECURITY INTERESTS IN REAL OR PERSONAL PROPERTY, (B) EXERCISE OF SELF-HELP REMEDIES (INCLUDING SET-OFF), (C) APPOINTMENT OF A RECEIVER AND (D) TEMPORARY, PROVISIONAL OR ANCILLARY REMEDIES (INCLUDING WRITS OF ATTACHMENT, WRITS OF POSSESSION, TEMPORARY RESTRAINING ORDERS OR PRELIMINARY INJUNCTIONS). THIS NOTE DOES NOT LIMIT THE RIGHT OF ANY PARTY TO EXERCISE OR OPPOSE ANY OF THE RIGHTS AND REMEDIES DESCRIBED IN CLAUSES (A) - (D) AND ANY SUCH EXERCISE OR OPPOSITION DOES NOT WAIVE THE RIGHT OF ANY PARTY TO A REFERENCE PROCEEDING PURSUANT TO THIS NOTE.

(3) UPON THE WRITTEN REQUEST OF ANY PARTY, THE PARTIES SHALL SELECT A SINGLE REFEREE, WHO SHALL BE A RETIRED JUDGE OR

 

14.


JUSTICE. IF THE PARTIES DO NOT AGREE UPON A REFEREE WITHIN TEN DAYS OF SUCH WRITTEN REQUEST, THEN, ANY PARTY MAY REQUEST THE COURT TO APPOINT A REFEREE PURSUANT TO CALIFORNIA CODE OF CIVIL PROCEDURE SECTION 640(B). A REQUEST FOR APPOINTMENT OF A REFEREE MAY BE HEARD ON AN EX PARTE OR EXPEDITED BASIS, AND THE PARTIES AGREE THAT IRREPARABLE HARM WOULD RESULT IF EX PARTE RELIEF IS NOT GRANTED.

(4) ALL PROCEEDINGS AND HEARINGS CONDUCTED BEFORE THE REFEREE, EXCEPT FOR TRIAL, SHALL BE CONDUCTED WITHOUT A COURT REPORTER, EXCEPT WHEN ANY PARTY SO REQUESTS, A COURT REPORTER WILL BE USED AND THE REFEREE WILL BE PROVIDED A COURTESY COPY OF THE TRANSCRIPT. THE PARTY MAKING SUCH REQUEST SHALL HAVE THE OBLIGATION TO ARRANGE FOR AND PAY COSTS OF THE COURT REPORTER, PROVIDED THAT SUCH COSTS, ALONG WITH THE REFEREE’S FEES, SHALL ULTIMATELY BE BORNE BY THE PARTY WHO DOES NOT PREVAIL, AS DETERMINED BY THE REFEREE.

(5) THE REFEREE SHALL APPLY THE RULES OF DISCOVERY AND EVIDENCE APPLICABLE TO PROCEEDINGS AT LAW IN THE STATE OF CALIFORNIA TO THE REFERENCE PROCEEDING AND SHALL DETERMINE ALL ISSUES IN ACCORDANCE WITH APPLICABLE LAW. THE REFEREE SHALL BE EMPOWERED TO ENTER EQUITABLE AS WELL AS LEGAL RELIEF AND RULE ON ANY MOTION WHICH WOULD BE AUTHORIZED IN A TRIAL, INCLUDING MOTIONS FOR DEFAULT JUDGMENT OR SUMMARY JUDGMENT. THE REFEREE SHALL REPORT HIS DECISION, WHICH REPORT SHALL ALSO INCLUDE FINDINGS OF FACT AND CONCLUSIONS OF LAW.

[Remainder of page left intentionally blank]

 

15.


IN WITNESS WHEREOF, the Borrower has duly executed this Note, as of the date first above written.

 

MARRONE BIO INNOVATIONS, INC.
By      

 

  Title:
Address:

 

 

 

[Signature Page to Senior Secured Promissory Note]


ANNEX I

DEFINITIONS

As used in the Note, the following terms shall have the following meanings:

“Acquired Indebtedness” means Indebtedness of a Person whose assets or stock is acquired by the Borrower in a Permitted Acquisition; provided , however , that such Indebtedness (i) was in existence prior to the date of such Permitted Acquisition, and (ii) was not incurred in connection with, or in contemplation of, such Permitted Acquisition.

“Capital Stock” means (a) in the case of a corporation, capital stock, (b) in the case of an association or business entity, any and all shares, interests, participations, rights or other equivalents (however designated) of capital stock, (c) in the case of a partnership, partnership interests (whether general or limited), (d) in the case of a limited liability company, membership interests, (e) any other interest or participation that confers on a Person the right to receive a share of the profits and losses of, or distributions of assets of, the issuing Person and (f) any and all warrants, rights or options to purchase any of the foregoing.

“Contingent Obligation” is, for any Person, any direct or indirect liability, contingent or not, of that Person for (a) any indebtedness, lease, dividend, letter of credit or other obligation of another such as an obligation directly or indirectly guaranteed, endorsed, co-made, discounted or sold with recourse by that Person, or for which that Person is directly or indirectly liable; (b) any obligations for undrawn letters of credit for the account of that Person; and (c) all obligations from any interest rate, currency or commodity swap agreement, interest rate cap or collar agreement, or other agreement or arrangement designated to protect a Person against fluctuation in interest rates, currency exchange rates or commodity prices; but “Contingent Obligation” does not include endorsements in the ordinary course of business. The amount of a Contingent Obligation is the stated or determined amount of the primary obligation for which the Contingent Obligation is made or, if not determinable, the maximum reasonably anticipated liability for it determined by the Person in good faith; but the amount may not exceed the maximum of the obligations under any guarantee or other support arrangement.

“Environmental Laws” means all federal, state or local laws, statutes, common law duties, rules, regulations, ordinances and codes, together with all administrative orders, directives, requests, licenses, authorizations and permits of, and agreements with (including consent decrees), any governmental agencies or authorities, in each case relating to or imposing liability or standards of conduct concerning public health, safety and environmental protection matters.

“ERISA” means the Employee Retirement Income Security Act of 1974, including (unless the context otherwise requires) any rules or regulations promulgated thereunder.

“Indebtedness” is (a) indebtedness for borrowed money or the deferred price of property or services, such as reimbursement and other obligations for surety bonds and letters of credit, (b) obligations evidenced by notes, bonds, debentures or similar instruments, (c) capital lease obligations and (d) Contingent Obligations.


“Key Person” means Pamela Marrone.

“Key Person Event” means the date on which the Key Person ceases to be employed as the chief executive officer of the Borrower, unless such cessation either (x) occurs after December 31, 2017 or (y) is a result of any of the following:

a. The Key Person dies or suffers a permanent disability, or other physical incapacity, that prevents her from discharging her duties as chief executive officer of the Borrower;

b. The Key Person (i) suffers a legal incapacity that prevents her from discharging her duties as chief executive officer of the Borrower or (ii) is otherwise prohibited from discharging her duties as chief executive officer of the Borrower due to any law, rule, or regulation or any final judgement, order or decree of any court or governmental agency; or

c. The Board, acting by the affirmative vote of at least 80% of the members of the Board (excluding the vote of the Key Person), removes the Key Person as chief executive officer of the Borrower.

“Lien” means any mortgage, deed of trust, pledge, security interest, assignment, deposit arrangement, charge or encumbrance, lien, or other type of preferential arrangement.

“Loan Documents” means the Purchase Agreement, the Note, the Security Agreement, the Subsidiary Guaranty, any Subordination Agreement, and all other certificates, documents, agreements and instruments required to be delivered to the Lender or the Agent under or in connection with the Note.

“Obligations” means the indebtedness, liabilities and other obligations of the Borrower to the Lender under or in connection with the Note and the other Loan Documents and, including, without limitation, all unpaid principal of the Note, all interest accrued thereon, all fees and all other amounts payable by the Borrower to the Lender thereunder or in connection therewith, whether now existing or hereafter arising, and whether due or to become due, absolute or contingent, liquidated or unliquidated, determined or undetermined, and including interest that accrues after the commencement by or against the Borrower of any bankruptcy or insolvency proceeding naming such Person as the debtor in such proceeding.

“Person” is any individual, sole proprietorship, partnership, limited liability company, joint venture, company, trust, unincorporated organization, association, corporation, institution, public benefit corporation, firm, joint stock company, estate, entity or government agency.

“Permitted Acquisition” means any acquisition made by the Borrower with the prior consent of the Lender.


Permitted Indebtedness” means:

 

(i) Indebtedness of the Borrower to the Lender;

 

(ii) Indebtedness of the Borrower existing on the date hereof and disclosed to the Lender on Schedule 6(i) and extensions, renewals and refinancings of such Indebtedness, provided that the principal amount of such Indebtedness is not increased except by an amount equal to a reasonable premium or other reasonable amount paid, and fees and expenses reasonably incurred, in connection with such extension, renewal or refinancing and by an amount equal to any existing unused commitments thereunder;

 

(iii) trade, utility or non-extraordinary accounts payable arising in the ordinary course of business;

 

(iv) Purchase Money Indebtedness;

 

(v) cash management agreements in the ordinary course of business;

 

(vi) Indebtedness arising from judgments or decrees in an aggregate principal amount outstanding at any time not to exceed $5,000,000;

 

(vii) sales rebates issued by the Borrower to customers in the ordinary course of business;

 

(viii) grants provided by the United States government in exchange for the Borrower’s obligation to purchase equipment specified by such grants or to fund research and development efforts specified in such grants;

 

(ix) Indebtedness that is incurred on the date of the consummation of a Permitted Acquisition solely for the purpose of consummating such Permitted Acquisition so long as no Event of Default has occurred and is continuing or would result therefrom;

 

(x) Acquired Indebtedness;

 

(xi) Indebtedness consisting of guarantees resulting from endorsement of negotiable instruments for collection by the Borrower in the ordinary course of business;

 

(xii) interest rate swaps, currency swaps and similar financial products entered into or obtained in the ordinary course of business;

 

(xiii) Subordinated Debt;

 

(xiv) Indebtedness of the Borrower to any of its wholly owned Subsidiaries;

 

(xv) Indebtedness of the Borrower pursuant to a working capital facility secured by a first priority security interest in the Borrower’s Accounts (as such term is defined in the UCC) and Inventory (as such term is defined in the UCC); and

 

(xviii) additional Indebtedness of the Borrower with the prior consent of the Lender.


“Purchase Money Indebtedness” means Indebtedness incurred to finance the acquisition of fixed assets, capital assets (whether pursuant to a loan, a capitalized lease or otherwise) or other assets (including manufacturing plants), including the development, furnishing and operation hereof.

“Subordinated Debt” means any Indebtedness of the Borrower subordinated to the Obligations and either subject to a Subordination Agreement or whereby the creditor or creditors for such Indebtedness unilaterally agree to subordinate fully the Borrower’s obligations to such creditor or creditors to all Indebtedness of the Borrower owing to the Lender in terms of rights of payment, liens and exercise of remedies.

“Subsidiary” means as to any Person, any corporation, partnership, limited liability company or other entity of which more than fifty percent (50%) of the outstanding Capital Stock having ordinary voting power to elect a majority of the board of directors (or equivalent governing body) or other managers of such corporation, partnership, limited liability company or other entity is at the time owned by (directly or indirectly) or the management is otherwise controlled by (directly or indirectly) such Person (irrespective of whether, at the time, Capital Stock of any other class or classes of such corporation, partnership, limited liability company or other entity shall have or might have voting power by reason of the happening of any contingency). Unless otherwise qualified, references to “Subsidiary” or “Subsidiaries” herein shall refer to those of the Borrower.

“Subsidiary Guarantor” means each new Subsidiary of Borrower formed after the date hereof that executes the Subsidiary Guaranty or a supplement to such Subsidiary Guaranty.

“Subsidiary Guaranty” means a guaranty executed and delivered in favor of the Lender by a new Subsidiary of Borrower formed after the date hereof.

“Subordination Agreement” means any subordination agreement with respect to Subordinated Debt among the Borrower, the applicable creditor(s) and the Lender or the Agent (on behalf of the Lender), in form and substance reasonably satisfactory to the Lender or the Agent (on behalf of the Lender).

“UCC” means the Uniform Commercial Code as the same may, from time to time, be in effect in the State of California.


SCHEDULES TO THE NOTE

Schedule 6(i)

Existing Indebtedness

Five Star Debt ” means indebtedness under the Business Loan Agreement, dated as of June 13, 2014, by and among the Borrower, Marrone Michigan Manufacturing, LLC (“ MMM ”) and Five Star Bank as lender, as amended by the Consent, dated as of August 19, 2015.

Snyder Debt ” means indebtedness under the Snyder Loan Agreement (Deal A).

Snyder Loan Agreement (Deal A) ” means the Loan Agreement, dated as of October 2, 2012, by and among the Borrower, the lenders from time to time party thereto, and Gordon Snyder, as administrative agent and collateral agent for such lenders, as amended by that Amendment and Consent, dated as of April 10, 2013, and that Omnibus Amendment to Loan Agreement, dated as of August 19, 2015, between the Borrower and Gordon Snyder as administrative agent and collateral agent for the lenders.

The Borrower (together with MMM) had an aggregate of approximately $1,502,000 outstanding under various capital leases and equipment leases, secured by liens set forth on Schedule 6(iv) .


SCHEDULES TO THE NOTE

Schedule 6(iv)

Existing Liens

 

   

Secured Party

   Initial Filing
Number
     Initial
Filing Date
     Collateral
Description
1  

Manufacturers’ Lease Plans, Inc.

     2009 2917117         9/11/2009       Equipment
2  

Thermo Fisher Financial Services Inc.

     2011 0842388         3/8/2011       Equipment
3  

Manufacturers’ Lease Plans, Inc.

     2011 1307423         4/7/2011       Equipment
4  

Manufacturers’ Lease Plans, Inc.

     2011 1486599         4/20/2011       Equipment
5  

Thermo Fisher Financial Services Inc.

     2012 1830845         5/11/2012       Equipment
6  

Manufacturers’ Lease Plans, Inc.

     2012 2469296         6/26/2012       Equipment
7  

Farnam Street Financial, Inc.

     2012 2776104         7/19/2012       Equipment
8  

Gordon Snyder, as agent

     2012 4188282         10/31/12       All assets
9  

Thermo Fisher Financial Services Inc.

     2013 0600800         2/14/2013       Equipment
10  

Thermo Fisher Financial Services Inc.

     2013 1743864         5/7/2013       Equipment
11  

Farnam Street Financial, Inc.

     2013 2466804         6/27/2013       Equipment
12  

Manufacturers’ Lease Plans, Inc.

     2014 2251668         6/10/2014       Equipment
13  

Five Star Bank

     2014 3526878         9/3/2014       All assets
of MMM
and MBI*

 

* Initial Financing Statement 2014-3526878 by Five Star Bank shall be amended on or around the date of this Note by Five Star Bank to amend the collateral description to all assets of MMM and the Borrower’s deposit accounts with Five Star Bank (#3207933 and #3208014) only.

Exhibit 4.2

EXECUTION COPY

FORM OF WARRANT

Warrant Certificate No.                 

THE SECURITIES REPRESENTED HEREBY (AND THE SECURITIES ISSUABLE UPON THE EXERCISE HEREOF) HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING SUCH SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

Effective Date: August 20, 2015    Void After: August 20, 2023

MARRONE BIO INNOVATIONS, INC.

WARRANT TO PURCHASE COMMON STOCK

Marrone Bio Innovations, Inc., a Delaware corporation (the “ Company ”), for value received on August 20, 2015 (the “ Effective Date ”), hereby issues to [            ] (the “ Holder ”) this Warrant (the “ Warrant ”) to purchase up to [            ] shares of the Company’s Common Stock (as defined below) at the Exercise Price (as defined below), as adjusted from time to time as provided herein, on or before August 20, 2023 (the “ Expiration Date ”), all subject to the following terms and conditions. The Warrant Shares (as defined below) issued upon exercise of this Warrant shall be subject to the provisions of the Company’s certificate of incorporation, as in effect from time to time. Unless otherwise defined in this Warrant, terms appearing in initial capitalized form shall have the meaning ascribed to them in that certain Purchase Agreement, dated as of August 20, 2015 by and among the Company, the Holder and certain other investors party thereto, entered into in connection with a private placement of the Company’s securities and pursuant to which this Warrant was issued (the “ Purchase Agreement ”). This Warrant, together with any other Warrants issued pursuant to the Purchase Agreement or upon the transfer or exchange of all or any part of such Warrant or Warrants, are collectively referred to as the “ Warrants ”, and any Holder, together with any other holder of Warrants, are collectively referred to as the “ Holders ”.

As used in this Warrant:

(i) Affiliate means any Person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, a Person, as such terms are used and construed in Rule 144 promulgated under the Securities Act of 1933, as amended (the Securities Act );


(ii) Business Day means any day other than Saturday, Sunday or any other day on which commercial banks in the City of New York, New York, are authorized or required by law or executive order to close;

(iii) “ Common Stock ” means (i) the Common Stock, par value $0.00001 per share, of the Company, and (ii) any share capital into which such Common Stock shall have been changed or any share capital resulting from a reclassification of such Common Stock;

(iv) Exercise Price means $1.91 per whole share of Common Stock, subject to adjustment as provided herein;

(v) Person means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof;

(vi) Trading Day means any day on which the Common Stock is traded on the primary national or regional stock exchange on which the Common Stock is listed, or if not so listed, the OTC Bulletin Board, if quoted thereon, is open for the transaction of business, provided that “Trading Day” shall not include any day on which the Common Stock is scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York City time); and

(viii) Warrant Shares ” means the shares of Common Stock issuable upon exercise of the Warrant, including any securities issued or issuable with respect thereto or into which or for which such shares may be exchanged, or converted, pursuant to any stock dividend, stock split, stock combination, recapitalization, reclassification, reorganization or other similar event.

 

1. DURATION AND EXERCISE OF WARRANT

(a) Exercise Period . Subject to the terms of this Warrant, the Holder may exercise this Warrant at any time and from time to time, in whole or in part, on any Business Day on or before 5:00 P.M., Eastern Time, on the Expiration Date, at which time this Warrant shall become void and of no value, and all rights hereunder shall thereupon cease.

(b) Exercise Procedures .

 

2


(i) While this Warrant remains outstanding and exercisable in accordance with Section 1(a), the Holder may exercise this Warrant, in whole or in part, as follows:

(A) By presentation and surrender of this Warrant to the Company at its principal offices or at such other office or agency as the Company may specify in writing to the Holder, with a duly executed copy of the Notice of Exercise attached as Exhibit A ; and

(B) Payment of the then-applicable Exercise Price per share multiplied by the number of Warrant Shares being purchased upon exercise of the Warrant (such amount, the “ Aggregate Exercise Price ”) made in the form of cash, or by certified check, bank draft or money order payable in lawful money of the United States of America or in the form of a Cashless Exercise (as defined below) to the extent permitted in Section 1(b)(ii) below.

(ii) In addition, while this Warrant remains outstanding and exercisable in accordance with Section 1(a), the Holder may also, in its sole discretion, exercise (so long as at the time of exercise, the fair market value (as defined below) exceeds the then-current Exercise Price) all or any part of the Warrant in a “cashless” or “net-issue” exercise (a “ Cashless Exercise ”) by delivering to the Company (1) the Notice of Exercise and (2) the original Warrant, pursuant to which the Holder shall surrender the right to receive upon exercise of this Warrant, a number of Warrant Shares having a fair market value (as determined below) equal to the Aggregate Exercise Price, in which case, the number of Warrant Shares to be issued to the Holder upon such exercise shall be calculated using the following formula:

 

X    

  =   Y * (A - B)
    A

 

with:       X =       the number of Warrant Shares to be issued to the Holder
  Y =   the number of Warrant Shares with respect to which the Warrant is being exercised
  A =   the fair market value per share of Common Stock on the date of exercise of the Warrant
  B =   the then-current Exercise Price of the Warrant

Solely for the purposes of this Section 1(b)(ii), “fair market value” per share of Common Stock shall mean (A) if the Common Stock is publicly traded, the average of the closing sales prices, as quoted on the primary national or regional stock exchange on which the Common Stock is listed, or, if not listed, the OTC Bulletin Board if quoted thereon, on the twenty (20) Trading Days immediately preceding the date on which the Notice of Exercise is deemed to have been sent to the Company, or (B) if the Common Stock is not publicly traded as set forth in clause (A) of this sentence, as reasonably and in good faith determined by the Board of Directors of the Company as of the date which the Notice of Exercise is deemed to have been sent to the Company (subject to Section 14).

For purposes of Rule 144(d) promulgated under the Securities Act, as in effect on the date hereof, it is intended that the Warrant Shares issued in a Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the date this Warrant was originally issued pursuant to the Purchase Agreement.

 

3


(iii) Upon the exercise of this Warrant in compliance with the provisions of this Section 1(b), the Company shall promptly issue and cause to be registered with the Company’s transfer agent (the “ Transfer Agent ”) a book entry position for the total number of Warrant Shares for which this Warrant is being exercised. Each exercise of this Warrant shall be effective immediately prior to the close of business on the date (the “ Date of Exercise ”) on which the conditions set forth in Section 1(b) have been satisfied. On or before the second Business Day following the date on which the Company has received each of the Notice of Exercise and the Aggregate Exercise Price (or notice of a Cashless Exercise in accordance with Section 1(b)(ii)) (the “ Exercise Delivery Documents ”), the Company shall transmit an acknowledgment of receipt of the Exercise Delivery Documents to the Transfer Agent. Upon delivery of the Exercise Delivery Documents, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Warrant Shares with respect to which this Warrant has been exercised. If the number of Warrant Shares represented by this Warrant is greater than the actual number of Warrant Shares being acquired upon such an exercise, then the Company shall as soon as practicable and in no event later than five (5) Business Days after any exercise, and at its own expense, issue a new Warrant of like tenor representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant is exercised.

(c) Exercise Limitations .

(i) Subject to the effect of a Fundamental Transaction as described in Section 3(c) below, the Company shall not effect any exercise of this Warrant, and a Holder shall not have the right to exercise any portion of this Warrant, to the extent that after giving effect to such issuance after exercise as set forth on the applicable Notice of Exercise, the Holder (together with the Holder’s Affiliates, and any other Person acting as a group together with the Holder or any of the Holder’s Affiliates) would beneficially own any Common Stock in excess of 19.99% of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon exercise of this Warrant (the “ Beneficial Ownership Limitation ”).

(ii) For purposes of the Section 1(c)(i), the number of shares of Common Stock beneficially owned by the Holder and its Affiliates shall include, in addition to outstanding shares of Common Stock held by the Holder and its Affiliates, (x) the number of shares of Common Stock issuable upon exercise of this Warrant with respect to which such determination is being made, (y) the number of shares of Common Stock issuable upon the exercise or conversion of the unexercised or nonconverted portion of any other securities of the Company exercisable or convertible into Common Stock beneficially owned by the Holder or any of its Affiliates or any other person acting as a group with the Holder or any of the Holder’s Affiliates, and (z) any other shares of Common Stock then beneficially owned by the Holder or any of its Affiliates or any other person acting as a group with the Holder or any of the Holder’s Affiliates, but shall exclude the number of shares of Common Stock which would be issuable upon exercise of the remaining, nonexercised portion of this Warrant beneficially owned by the Holder

 

4


or any of its Affiliates. Except as set forth in the preceding sentence, for purposes of this Section 1(c), beneficial ownership shall be calculated in accordance with Section 13(d) of the Exchange Act, as amended (the “Exchange Act ) and the rules and regulations promulgated thereunder, it being acknowledged by the Holder that the Company is not representing to the Holder that such calculation is in compliance with Section 13(d) of the Exchange Act and the Holder is solely responsible for any schedules required to be filed in accordance therewith. To the extent that the limitation contained in this Section 1(c) applies, the determination of which portion of this Warrant is exercisable shall be in the sole discretion of the Company, provided that the submission of a Notice of Exercise shall be deemed to be the Holder’s determination of which portion of this Warrant is exercisable, subject to the Beneficial Ownership Limitation, and shall be considered a representation to the Company that the Beneficial Ownership Limitation shall not be exceeded, and the Company may rely on such representation, with no obligation to verify or confirm the accuracy of such representation, in making its own determination. In addition, a determination as to any group status as contemplated above shall be determined in accordance with Section 13(d) of the Exchange Act and the rules and regulations promulgated thereunder. For purposes of this Section 1(c), in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock as of the most recent date reflected in (A) the Company’s most recent periodic or annual report, as the case may be, (B) a more recent public announcement by the Company and (C) any other notice by the Company or the Transfer Agent to the Holder setting forth the number of shares of Common Stock outstanding. Upon the written or oral request of a Holder, the Company shall within two Trading Days confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant, by the Holder or its Affiliates since the date as of which such number of outstanding shares of Common Stock was reported. The provisions of this Section 1(c) shall be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(c) to correct this Section 1(c) (or any portion hereof) which may be defective or inconsistent with the intended Beneficial Ownership Limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such limitation. The limitations contained in this paragraph shall apply to a successor holder of this Warrant.

(d) Partial Exercise . This Warrant shall be exercisable, either in its entirety or, from time to time, for only part of the number of Warrant Shares referenced by this Warrant. If this Warrant is exercised in part, the Company shall issue, at its expense, a new Warrant, in substantially the form of this Warrant, referencing such reduced number of Warrant Shares that remain subject to this Warrant.

(e) Disputes . In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are not disputed and resolve such dispute in accordance with Section 15.

 

5


2. ISSUANCE OF WARRANT SHARES

(a) The Company covenants that all Warrant Shares will, upon issuance in accordance with the terms of this Warrant, be (i) duly authorized, fully paid and non-assessable, and (ii) free from all liens, charges and security interests, with the exception of claims arising through the acts or omissions of the Holder and except as arising from applicable federal and state securities laws.

(b) The Company shall register this Warrant upon records to be maintained by the Company for that purpose in the name of the record holder of such Warrant from time to time. The Company may deem and treat the registered Holder of this Warrant as the absolute owner thereof for the purpose of any exercise thereof, any distribution to the Holder thereof and for all other purposes.

(c) The Company will not, by amendment of its certificate of incorporation or bylaws or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities or any other voluntary action, avoid or seek to avoid the observance or performance of any of the terms to be observed or performed hereunder by the Company, but will at all times in good faith assist in the carrying out of all the provisions of this Warrant and in the taking of all action necessary or appropriate in order to protect the rights of the Holder to exercise this Warrant, or against impairment of such rights.

 

3. ADJUSTMENTS OF EXERCISE PRICE, NUMBER AND TYPE OF WARRANT SHARES; FUNDAMENTAL TRANSACTION

(a) The Exercise Price and the number of shares purchasable upon the exercise of this Warrant shall be subject to adjustment from time to time upon the occurrence of certain events described in this Section 3(a); provided , that notwithstanding the provisions of this Section 3(a), the Company shall not be required to make any adjustment if and to the extent that such adjustment would require the Company to issue a number of shares of Common Stock in excess of its authorized but unissued shares of Common Stock, less all shares of Common Stock that have been reserved for issuance upon the conversion of all outstanding securities convertible into shares of Common Stock and the exercise of all outstanding options, warrants and other rights exercisable for shares of Common Stock. If the Company does not have the requisite number of authorized but unissued shares of Common Stock to make any adjustment, the Company shall use commercially reasonable efforts to obtain the necessary shareholder consent to increase the authorized number of shares of Common Stock to make such an adjustment pursuant to this Section 3(a).

(i) Subdivision or Combination of Stock . If the Company at any time after the date of issuance of this Warrant subdivides (by any stock split, stock dividend, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision shall be proportionately reduced and the number of Warrant Shares shall be proportionately increased. If the Company at any time after the date of issuance of this Warrant combines (by combination, reverse stock split or otherwise) its outstanding shares of Common Stock into a smaller number of shares, the

 

6


Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares shall be proportionately decreased. Any adjustment under this Section 3(a)(i) shall become effective at the close of business on the date the subdivision or combination becomes effective. The Exercise Price and the Warrant Shares, as so adjusted, shall be readjusted in the same manner upon the happening of any successive event or events described in this Section 3(a)(i).

(ii) Distribution of Assets . If at any time or from time to time the holders of Common Stock (or any shares of stock or other securities at the time receivable upon the exercise of this Warrant) shall have received or become entitled to receive, without payment therefore: (x) Common Stock or any shares of stock or other securities which are at any time directly or indirectly convertible into or exchangeable for Common Stock, or any rights or options to subscribe for, purchase or otherwise acquire any of the foregoing by way of dividend or other distribution (other than a dividend or distribution covered in Section 3(a)(i) above); (y) any cash paid or payable otherwise than as a cash dividend; or (z) Common Stock or additional stock or other securities or property (including cash) by way of spinoff, split-up, reclassification, combination of shares or similar corporate rearrangement (other than shares of Common Stock pursuant to Section 3(a)(i) above); then and in each such case, the Holder hereof will, upon the exercise of this Warrant, be entitled to receive, in addition to the number of shares of Common Stock receivable thereupon, and without payment of any additional consideration therefor, the amount of stock and other securities and property (including cash in the cases referred to in clauses (y) and (z) above) which such Holder would hold on the date of such exercise had such Holder been the holder of record of such Common Stock as of the date on which holders of Common Stock received or became entitled to receive such shares or all other additional stock and other securities and property.

(b) Certificate as to Adjustments . Upon the occurrence of each adjustment or readjustment pursuant to this Section 3, the Company at its expense shall promptly compute such adjustment or readjustment in accordance with the terms hereof and furnish to the Holder of this Warrant a certificate setting forth such adjustment or readjustment and showing in detail the facts upon which such adjustment or readjustment is based. The Company shall promptly furnish or cause to be furnished to the Holder a like certificate setting forth: (i) such adjustments and readjustments; and (ii) the number of shares and the amount, if any, of other property which at the time would be received upon the exercise of the Warrant.

(c) Fundamental Transaction . If, at any time while this Warrant is outstanding, (i) the Company, directly or indirectly, in one or more related transactions effects any merger or consolidation of the Company with or into another Person (but excluding a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company), (ii) the Company, directly or indirectly, effects any sale, assignment, transfer or other disposition of all or substantially all of its assets in one or a series of related transactions, (iii) any, direct or indirect, purchase offer, tender offer or exchange offer (whether by the Company or another Person) is completed pursuant to which holders of Common Stock are permitted to sell, tender or exchange their shares for other securities, cash or property and has been accepted by the holders of 50% or more of the outstanding Common Stock or (iv) the Company, directly or indirectly, in one or more related transactions effects any reclassification, reorganization or recapitalization of

 

7


the Common Stock or any compulsory share exchange pursuant to which the Common Stock is effectively converted into or exchanged for other securities, cash or property (each a “Fundamental Transaction ), then, the Company shall cause this Warrant to be redeemed in connection with such Fundamental Transaction (which shall include an express provision in the definitive agreement related to such Fundamental Transaction to obligate the parties to effectuate the redemption or similar repurchase or “cash out” of the Warrant as contemplated in this Section 3(c)) for the same consideration that would have been payable in respect of all of the Warrant Shares that would have been issuable to the Holder if this Warrant had been fully exercised by Cashless Exercise on the date of, and immediately prior to, the Fundamental Transaction (without regard to any limitation in Section 1(c) on exercise of this Warrant); for the avoidance of doubt, the Holder shall be entitled to be paid at least the same per share consideration as the other holders of the Company’s Common Stock in connection with any such Fundamental Transaction, without regard to the Beneficial Ownership Limitation.

 

4. TRANSFERS AND EXCHANGES OF WARRANT AND WARRANT SHARES

(a) Registration of Transfers and Exchanges . Subject to Section 4(c), upon the Holder’s surrender of this Warrant, with a duly executed copy of the Form of Assignment attached as Exhibit B , to the Secretary of the Company at its principal offices or at such other office or agency as the Company may specify in writing to the Holder, the Company shall register the transfer of all or any portion of this Warrant. Upon such registration of transfer, the Company shall issue a new Warrant, in substantially the form of this Warrant, evidencing the acquisition rights transferred to the transferee and a new Warrant, in similar form, evidencing the remaining acquisition rights not transferred, to the Holder requesting the transfer.

(b) Warrant Exchangeable for Different Denominations . The Holder may exchange this Warrant for a new Warrant or Warrants, in substantially the form of this Warrant, evidencing in the aggregate the right to purchase the number of Warrant Shares that may then be purchased hereunder, each of such new Warrants to be dated the date of such exchange and to represent the right to purchase such number of Warrant Shares as shall be designated by the Holder. The Holder shall surrender this Warrant with duly executed instructions regarding such re-certification of this Warrant to the Secretary of the Company at its principal offices or at such other office or agency as the Company may specify in writing to the Holder.

(c) Warrant not Transferrable; Restrictions on Transfers . This Warrant may not be transferred at any time without both (x) the consent of the Company, in its sole discretion, and (y) either (i) registration under the Securities Act or (ii) an exemption from such registration and a written opinion of legal counsel addressed to the Company that the proposed transfer of the Warrant may be effected without registration under the Securities Act, which opinion will be in form and from counsel reasonably satisfactory to the Company.

(d) Permitted Transfers and Assignments . Notwithstanding any provision to the contrary in this Section 4, the Holder may transfer, with or without consideration, this Warrant or any of the Warrant Shares (or a portion thereof) to the Holder’s Affiliates (as such term is defined under Rule 144 of the Securities Act) without obtaining the consent of the Company or the opinion from counsel that may be required by Section 4(c)(ii); provided that the Holder

 

8


delivers to the Company and its counsel certification, documentation, and other assurances reasonably required by the Company’s counsel to enable the Company’s counsel to render an opinion to the Company’s Transfer Agent that such transfer does not violate applicable securities laws.

 

5. MUTILATED OR MISSING WARRANT CERTIFICATE

If this Warrant is mutilated, lost, stolen or destroyed, upon request by the Holder, the Company will, at its expense, issue, in exchange for and upon cancellation of the mutilated Warrant, or in substitution for the lost, stolen or destroyed Warrant, a new Warrant, in substantially the form of this Warrant, representing the right to acquire the equivalent number of Warrant Shares; provided that, as a prerequisite to the issuance of a substitute Warrant, the Company may require satisfactory evidence of loss, theft or destruction as well as an indemnity from the Holder of a lost, stolen or destroyed Warrant.

 

6. PAYMENT OF TAXES

The Company shall not be required to pay any tax in respect of the preparation, issuance, delivery or transfer of this Warrant or the Warrant Shares to the Holder or any other Person.

 

7. FRACTIONAL WARRANT SHARES

No fractional Warrant Shares shall be issued upon exercise of this Warrant. The Company, in lieu of issuing any fractional Warrant Share, shall round up the number of Warrant Shares issuable to nearest whole share. The Company shall not be required to make any cash or other adjustment in respect of such fraction of a share to which the Holder would otherwise be entitled.

 

8. NO EQUITY INTEREST RIGHTS AND LEGEND

No holder of this Warrant, as such, shall be entitled to vote or be deemed the holder of any other securities of the Company that may at any time be issuable on the exercise hereof, nor shall anything contained herein be construed to confer upon the holder of this Warrant, as such, the rights of a shareholder of the Company or the right to vote for the election of directors or upon any matter submitted to shareholders at any meeting thereof, or give or withhold consent to any corporate action or to receive notice of meetings or other actions affecting shareholders (except as provided herein), or to receive dividends or subscription rights or otherwise (except as provide herein).

Each certificate or book entry position for Warrant Shares initially issued upon the exercise of this Warrant, and each certificate or book entry position for Warrant Shares issued to any subsequent transferee of such Warrant Shares, shall be stamped or otherwise imprinted with a legend in substantially the following form:

THE SECURITIES REPRESENTED HEREBY HAVE BEEN ISSUED PURSUANT TO AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES

 

9


SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES FOR THE BENEFIT OF THE COMPANY THAT SUCH SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED UNLESS THE SECURITIES ARE REGISTERED UNDER THE SECURITIES ACT OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT IS AVAILABLE. IN ADDITION, HEDGING TRANSACTIONS INVOLVING SUCH SECURITIES MAY NOT BE CONDUCTED UNLESS IN COMPLIANCE WITH THE SECURITIES ACT.

 

9. NOTICES

All notices, consents, waivers and other communications under this Warrant must be in writing and will be deemed given to a party: (a) when delivered to the appropriate address of the Holder or the Company, as applicable, by hand or by nationally recognized overnight courier service (costs prepaid); (b) when sent by facsimile or e-mail to the Holder or the Company, as applicable, with confirmation of transmission by the transmitting equipment; (c) when received or rejected by the addressee, if sent by certified mail, return receipt requested, to the Holder or the Company, as applicable; or (d) seven days after the placement of the notice into the mails (first class postage prepaid), to the Holder or the Company, as applicable. Such notices shall be sent, if to the Holder, to the address, facsimile number or e-mail address furnished by the registered Holder to the Company in accordance with the Purchase Agreement, or if to the Company, to it at 1540 Drew Ave., Davis CA 95618, Attention: Linda V. Moore, General Counsel (or to such other address, facsimile number or e-mail address as the Holder or the Company as a party may designate by notice the other party) with a copy to Morrison & Foerster LLP, 400 Capitol Mall, Suite 2600, Sacramento, CA 95814, Attention: Charles S. Farman, Esq.

 

10. SEVERABILITY

If a court of competent jurisdiction holds any provision of this Warrant invalid or unenforceable, the other provisions of this Warrant will remain in full force and effect. Any provision of this Warrant held invalid or unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable.

 

11. BINDING EFFECT

This Warrant shall be binding upon and inure to the sole and exclusive benefit of the Company, its successors and assigns, the registered Holder or Holders from time to time of this Warrant and the Warrant Shares.

 

12. SURVIVAL OF RIGHTS AND DUTIES

This Warrant shall terminate and be of no further force and effect on the earlier of 5:00 P.M., Eastern Time, on the Expiration Date or the date on which this Warrant has been exercised in full.

 

10


13. GOVERNING LAW

This Warrant shall be governed by and construed in accordance with California law without giving effect to any choice of law rule that would cause the application of the laws of any jurisdiction other than the internal laws of the State of California to the rights and duties of the parties.

 

14. DISPUTE RESOLUTION

In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via facsimile within two (2) Business Days of receipt of the Notice of Exercise giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price or the Warrant Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business Days, submit via facsimile the disputed determination of the Exercise Price to an independent, reputable investment bank or accounting firm selected by the Company and approved by the Holder. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

 

15. NOTICES OF RECORD DATE

Upon (a) any establishment by the Company of a record date of the holders of any class of securities for the purpose of determining the holders thereof who are entitled to receive any dividend or other distribution, or right or option to acquire securities of the Company, or any other right, or (b) any capital reorganization, reclassification, recapitalization, merger or consolidation of the Company with or into any other corporation, any transfer of all or substantially all the assets of the Company, or any voluntary or involuntary dissolution, liquidation or winding up of the Company, or the sale, in a single transaction, of a majority of the Company’s voting equity securities (whether newly issued, or from treasury, or previously issued and then outstanding, or any combination thereof), the Company shall mail to the Holder at least ten (10) Business Days, or such longer period as may be required by law, prior to the record date specified therein, a notice specifying (i) the date established as the record date for the purpose of such dividend, distribution, option or right and a description of such dividend, option or right, (ii) the date on which any such reorganization, reclassification, transfer, consolidation, merger, dissolution, liquidation or winding up, or sale is expected to become effective and (iii) the date, if any, fixed as to when the holders of record of Common Stock shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such reorganization, reclassification, transfer, consolidation, merger, dissolution, liquidation or winding up.

 

11


16. RESERVATION OF SHARES

The Company shall reserve and keep available out of its authorized but unissued shares of Common Stock for issuance upon the exercise of this Warrant, free from pre-emptive rights, such number of shares of Common Stock for which this Warrant shall from time to time be exercisable. The Company will take all such reasonable action as may be necessary to assure that such Warrant Shares may be issued as provided herein without violation of any applicable law or regulation. Without limiting the generality of the foregoing, the Company covenants that it will use commercially reasonable efforts to take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and non-assessable Warrant Shares upon the exercise of this Warrant and use commercially reasonable efforts to obtain all such authorizations, exemptions or consents, including but not limited to consents from the Company’s shareholders or Board of Directors or any public regulatory body, as may be necessary to enable the Company to perform its obligations under this Warrant.

 

17. HEADINGS

The headings used in this Warrant are for the convenience of reference only and shall not, for any purpose, be deemed a part of this Warrant.

 

18. AMENDMENT AND WAIVERS

Any term of this Warrant may be amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), with the written consent of the Company and the Holders of a majority of the Warrant Shares issuable upon exercise of the Warrants.

 

19. NO THIRD PARTY RIGHTS

This Warrant is not intended, and will not be construed, to create any rights in any parties other than the Company and the Holder, and no Person may assert any rights as third-party beneficiary hereunder.

SIGNATURE PAGE FOLLOWS

 

12


IN WITNESS WHEREOF, the Company has caused this Warrant to be duly executed as of the date first set forth above.

 

MARRONE BIO INNOVATIONS, INC.

                By:  

             

 

Name:

 

Title:


EXHIBIT A

NOTICE OF EXERCISE

(To be executed by the Holder of Warrant if such Holder desires to exercise Warrant)

To Marrone Bio Innovations, Inc.:

The undersigned hereby irrevocably elects to exercise this Warrant and to purchase thereunder,             full shares of Marrone Bio Innovations, Inc. common stock issuable upon exercise of the Warrant and delivery of:

(1) $            (in cash as provided for in the foregoing Warrant) and any applicable taxes payable by the undersigned pursuant to such Warrant; and

(2)             shares of Common Stock (pursuant to a Cashless Exercise in accordance with Section 1(b)(ii) of the Warrant) (check here if the undersigned desires to deliver an unspecified number of shares equal the number sufficient to effect a Cashless Exercise).

The undersigned requests that such shares be issued in the name of:

 

 

(Please print name, address and social security or federal employer
identification number (if applicable))

 

 

If the shares issuable upon this exercise of the Warrant are not all of the Warrant Shares which the Holder is entitled to acquire upon the exercise of the Warrant, the undersigned requests that a new Warrant evidencing the rights not so exercised be issued in the name of and delivered to:

 

 

(Please print name, address and social security or federal employer

identification number (if applicable))

 

 

 

Name of Holder (print): 

   

(Signature): 

   

(By:) 

   

Title: 

   

Dated: 

   

 


EXHIBIT B

FORM OF ASSIGNMENT

FOR VALUE RECEIVED,                     hereby sells, assigns and transfers to each assignee set forth below all of the rights of the undersigned under the Warrant (as defined in and evidenced by the attached Warrant) to acquire the number of Warrant Shares set opposite the name of such assignee below and in and to the foregoing Warrant with respect to said acquisition rights and the shares issuable upon exercise of the Warrant:

 

Name of Assignee

   Address    Number of Warrant Shares
     
     
     
     

If the total of the Warrant Shares are not all of the Warrant Shares evidenced by the foregoing Warrant, the undersigned requests that a new Warrant evidencing the right to acquire the Warrant Shares not so assigned be issued in the name of and delivered to the undersigned.

Name of Holder (print): 

   

(Signature): 

   

(By:) 

   

Title: 

   

Dated: 

   

Exhibit 10.1

EXECUTION COPY

SECURITY AGREEMENT

THIS SECURITY AGREEMENT (this “Agreement”), dated as of August 20, 2015, is made between MARRONE BIO INNOVATIONS, INC., a Delaware corporation (“Debtor”), IVY INVESTMENT MANAGEMENT COMPANY, a Delaware corporation (“Secured Party”), as agent for the benefit of Investors (defined below), and the Investors.

Debtor and Secured Party hereby agree as follows:

SECTION 1 Definitions; Interpretation .

(a) All capitalized terms used in this Agreement and not otherwise defined herein shall have the meanings assigned to them in the Note.

(b) As used in this Agreement, the following terms shall have the following meanings:

Collateral ” has the meaning set forth in Section 2.

Event of Default ” has the meaning set forth in Section 7.

Excluded Accounts ” means each deposit account listed on Schedule 5 on the date hereof, all accessions, additions, replacements, and substitutions to such deposit accounts; all records of any kind relating to such deposit accounts; all proceeds relating to such deposit accounts (including insurance, general intangible and other account proceeds).

Investors ” means the holders of the Note and their permitted assignees and successors.

Loan Documents ” has the meaning set forth in the Note.

Note ” means each Senior Secured Promissory Note dated August 20, 2015 made by Debtor in favor of Ivy Science & Technology Fund, Waddell & Reed Advisors Science & Technology Fund and Ivy Funds VIP Science & Technology, as amended, modified, renewed, extended or replaced from time to time.

Partnership and LLC Collateral ” has the meaning set forth in Section 5.

Permitted Lien ” has the meaning set forth in the Note.

Pledged Collateral ” means Debtor’s (i) investment property and (ii) Partnership and LLC Collateral, including any ownership interests in any subsidiaries of Debtor.

Pledged Collateral Agreements ” means any shareholders agreement, operating agreement, partnership agreement, voting trust, proxy agreement or other agreement or understanding with respect to any Pledged Collateral.


(c) Where applicable and except as otherwise defined herein, terms used in this Agreement shall have the meanings assigned to them in the UCC.

(d) In this Agreement, (i) the meaning of defined terms shall be equally applicable to both the singular and plural forms of the terms defined; and (ii) the captions and headings are for convenience of reference only and shall not affect the construction of this Agreement.

SECTION 2 Security Interest . As security for the payment and performance of the Obligations, Debtor hereby grants to Secured Party, as agent for the benefit of the Investors, a security interest in all of Debtor’s right, title and interest in, to and under all of its personal property, wherever located and whether now existing or owned or hereafter acquired or arising, including all accounts, chattel paper, commercial tort claims, deposit accounts, documents, equipment (including all fixtures), general intangibles, instruments, inventory, investment property, letter-of-credit rights, other goods, money and all products, proceeds and supporting obligations of any and all of the foregoing (collectively, the “Collateral”). This Agreement shall create a continuing security interest in the Collateral which shall remain in effect until terminated in accordance with Section 18 hereof.

Anything herein to the contrary notwithstanding, in no event shall the Collateral include, and Debtor shall not be deemed to have granted a security interest in, any of Debtor’s right, title or interest in (A) any of the outstanding voting capital stock or other ownership interests of a Controlled Foreign Corporation (as defined below) in excess of 65% of the voting power of all classes of capital stock or other ownership interests of such Controlled Foreign Corporation entitled to vote; provided that (i) immediately upon the amendment of the Internal Revenue Code to allow the pledge of a greater percentage of the voting power of capital stock or other ownership interests in a Controlled Foreign Corporation without adverse tax consequences, the Collateral shall include, and Debtor shall be deemed to have granted a security interest in, such greater percentage of capital stock or other ownership interests of each Controlled Foreign Corporation; and (ii) if no adverse tax consequences to Debtor shall arise or exist in connection with the pledge of any Controlled Foreign Corporation, the Collateral shall include, and Debtor shall be deemed to have granted a security interest in, such Controlled Foreign Corporation. As used herein, “Controlled Foreign Corporation” shall mean a “controlled foreign corporation” as defined in the Internal Revenue Code; (B) any lease, license, contract, or agreement, as such, or the assets subject thereto, if under the terms of such lease, license, contract, or agreement, or applicable law with respect thereto, the valid grant of a security interest or lien therein or in such assets to the Secured Party is prohibited and such prohibition has not been or is not waived or the consent of the other party to such lease, license, contract, or agreement has not been or is not otherwise obtained or under applicable law such prohibition cannot be waived; provided that the foregoing exclusion shall in no way be (a) construed to apply if any such prohibition would be rendered ineffective under the UCC or other applicable law or principles of equity, (b) construed so as to limit, impair or otherwise affect the Secured Party’s unconditional continuing security interests in and liens upon any rights or interests of the Debtor in or to the proceeds thereof, including monies due or to become due under any such lease, license, contract, or agreement (including any Accounts), in each case, that are not subject to such prohibitions, or (c) construed to apply at such time as the condition causing such prohibition shall be remedied and, to the extent severable, “Collateral” shall include any portion of such lease, license, contract, agreement or assets subject thereto that does not result in such prohibition; or (C) any Excluded Accounts.

 

2


SECTION 3 Financing Statements and other Action .

(a) Debtor hereby authorizes Secured Party to file at any time and from time to time any financing statements describing the Collateral, and Debtor shall execute and deliver to Secured Party, and Debtor hereby authorizes Secured Party to file (with or without Debtor’s signature), at any time and from time to time, all amendments to financing statements, assignments, continuation financing statements, termination statements, account control agreements, and other documents and instruments, in form reasonably satisfactory to Secured Party, as Secured Party may reasonably request, to perfect and continue perfected, maintain the priority of or provide notice of the security interest of Secured Party in the Collateral and to accomplish the purposes of this Agreement. Without limiting the generality of the foregoing, Debtor ratifies and authorizes the filing by Secured Party of any financing statements filed prior to the date hereof.

(b) Provided that the Snyder Loan Agreement has been terminated, Debtor will notify any third party who has possession of any Collateral of Secured Party’s security interest therein and use commercially reasonable efforts to obtain an acknowledgment from the third party that it is holding the Collateral for the benefit of Secured Party.

(c) Provided that the Snyder Loan Agreement has been terminated, Debtor (i) shall cause certificates to be issued in respect of any uncertificated Pledged Collateral, (ii) shall exchange certificated Pledged Collateral for certificates of larger or smaller denominations, and (iii) shall cause any securities intermediaries to show on their books that Secured Party is the entitlement holder with respect to any Pledged Collateral.

(d) Provided that the Snyder Loan Agreement has been terminated, Debtor shall deliver to Secured Party, appropriately endorsed or accompanied by appropriate instruments of transfer or assignment, all documents and instruments, all certificated Pledged Collateral, all letters of credit and all accounts and other rights of payment at any time evidenced by promissory notes, trade acceptances or other instruments.

(e) Debtor shall deliver to Secured Party such short-form security agreements and take such other action as Secured Party may deem necessary or reasonably desirable to record or otherwise perfect the interests of Secured Party in respect of that portion of the Collateral consisting of intellectual property.

(f) Debtor shall maintain the security interest created by this Agreement as a perfected security interest, subject only to Permitted Liens, and shall defend such security interest against the claims and demands of all Persons (other than holder of Permitted Liens).

(g) Debtor will from time to time furnish to Secured Party, at Secured Party’s reasonable request, statements and schedules further identifying and describing the assets and property of Debtor.

 

3


SECTION 4 Representations and Warranties . Debtor represents and warrants to Secured Party that:

(a) Debtor’s chief executive office and principal place of business (as of the date of this Agreement) is located at the address set forth in Schedule 1 ; Debtor’s jurisdiction of organization is set forth in Schedule 1 ; Debtor’s exact legal name is as set forth in the first paragraph of this Agreement; and all other locations where Debtor conducts business or Collateral is kept (as of the date of this Agreement) are set forth in Schedule 2 .

(b) Debtor has rights in or the power to transfer the Collateral, and Debtor is the sole and complete owner of the Collateral, free from any Lien other than Permitted Liens.

(c) All of Debtor’s U.S. and foreign patents and patent applications, copyrights (whether or not registered), applications for copyright, trademarks, service marks and trade names (whether registered or unregistered), and applications for registration of such trademarks, service marks and trade names, are set forth in Schedule 2 .

(d) Except as set forth in Schedule 3 , no control agreements exist with respect to any Collateral other than control agreements in favor of Secured Party.

(e) The names and addresses of all financial institutions and other Persons at which Debtor maintains its deposit and securities accounts, and the account numbers and account names of such accounts, are set forth in Schedule 1 .

(f) Schedule 4 lists Debtor’s ownership interests in each of its subsidiaries as of the date hereof.

(g) Debtor is and will be the legal record and beneficial owner of all Pledged Collateral, and has and will have good and marketable title thereto.

(h) Except as disclosed in writing to Secured Party, there are no Pledged Collateral Agreements which affect or relate to the voting or giving of written consents with respect to any of the Pledged Collateral. Each Pledged Collateral Agreement contains the entire agreement between the parties thereto with respect to the subject matter thereof, has not been amended or modified, and is in full force and effect in accordance with its terms. To the best knowledge of Debtor, there exists no material violation or material default under any Pledged Collateral Agreement by Debtor or the other parties thereto. Debtor has not knowingly waived or released any of its material rights under or otherwise consented to a material departure from the terms and provisions of any Pledged Collateral Agreement.

SECTION 5 Covenants . So long as any of the Obligations remain unsatisfied, Debtor agrees that:

(a) Debtor shall appear in and defend any action, suit or proceeding which may affect to a material extent its title to, or right or interest in, or Secured Party’s right or interest in, the Collateral, and shall do and perform all reasonable acts that may be necessary and appropriate to maintain, preserve and protect the Collateral.

 

4


(b) Debtor shall comply in all material respects with all laws, regulations and ordinances, and all policies of insurance, relating in a material way to the possession, operation, maintenance and control of the Collateral.

(c) Debtor shall give prompt written notice to Secured Party (and in any event not later than 30 days prior to any change described below in this subsection) of: (i) any change in the location of Debtor’s chief executive office or principal place of business; (ii) (iii) any change in its name; (iv) any changes in its identity or structure in any manner which might make any financing statement filed hereunder incorrect or misleading; (v) any change in its registration as an organization (or any new such registration); or (vi) any change in its jurisdiction of organization; provided that Debtor shall not locate any Collateral outside of the United States nor shall Debtor change its jurisdiction of organization to a jurisdiction outside of the United States, and Debtor shall give prompt written notice to Secured Party if, and in any event not later than 30 days after, it changes any locations set forth in Schedule 1 (other than its chief executive office or principal place of business) where it locates Collateral. In each case above, Debtor shall ensure that Secured Party maintains a valid, perfected Lien on the Collateral, subject only to Permitted Liens.

(d) Debtor shall carry and maintain in full force and effect, at its own expense and with financially sound and reputable insurance companies, insurance with respect to the Collateral in such amounts, with such deductibles and covering such risks as is customarily carried by companies engaged in the same or similar businesses and owning similar properties in the localities where Debtor operates. Within 30 days of the date hereof, all such insurance shall (i) name Secured Party for the benefit of the Lenders as loss payee (to the extent covering risk of loss or damage to tangible property) and as an additional named insured as its interests may appear (to the extent covering any other risk), (ii) provide that no cancellation, material reduction in amount or material change in coverage thereof shall be effective until at least thirty (30) days after receipt by Secured Party of written notice thereof and (iii) be reasonably satisfactory in all other respects to Secured Party.

(e) Debtor shall keep the Collateral free of all Liens except Permitted Liens.

(f) Debtor shall pay and discharge all taxes, fees, assessments and governmental charges or levies imposed upon it with respect to the Collateral prior to the date on which penalties attach thereto, except to the extent such taxes, fees, assessments or governmental charges or levies are being contested in good faith by appropriate proceedings.

(g) Debtor shall maintain and preserve its legal existence, its rights to transact business and all other rights, franchises and privileges necessary or desirable in the normal course of its business and operations and the ownership of the Collateral, except in connection with any transactions expressly permitted by the Note.

(h) If and when Debtor shall obtain ownership rights to any new patents, trademarks, service marks, trade names or copyrights, or otherwise acquire or become entitled to the benefit of, or apply for registration of, any of the foregoing, Debtor (i) shall promptly notify Secured Party thereof and (ii) hereby authorizes Secured Party to modify, amend, or supplement Schedule 2 and from time to time to include any of the foregoing and make all necessary or appropriate filings with respect thereto.

 

5


(i) Without limiting the generality of subsection (i), Debtor shall not register with the U.S. Copyright Office any unregistered copyrights (whether in existence on the date hereof or thereafter acquired, arising, or developed) unless Debtor provides Secured Party with written notice of its intent to register such copyrights not less than 30 days prior to the date of the proposed registration.

(j) At Secured Party’s reasonable request, Debtor will use commercially reasonable efforts to obtain from each Person from whom Debtor leases any premises, and from each other Person at whose premises any Collateral is at any time present (including any bailee, warehouseman or similar Person), any such collateral access, subordination, landlord waiver, bailment, consent and estoppel agreements as Secured Party may require, in form and substance satisfactory to Secured Party.

(k) In the event that Debtor acquires rights in any subsidiary after the date hereof, it shall deliver to Secured Party a completed supplement to Schedule 4 , reflecting such new subsidiary. Notwithstanding the foregoing, it is understood and agreed that the security interest of Secured Party shall attach to the equity interests of any such subsidiary immediately upon Debtor’s acquisition of rights therein and shall not be affected by the failure of Debtor to deliver any such supplement to Schedule 4 .

SECTION 6 Rights of Secured Party; Authorization; Appointment .

(a) At the request of Secured Party, upon the occurrence and during the continuance of any Event of Default, all remittances received by Debtor in respect of its accounts and other rights to payment shall be held in trust for Secured Party and, in accordance with Secured Party’s instructions, remitted to Secured Party or deposited to an account of Secured Party in the form received (with any necessary endorsements or instruments of assignment or transfer).

(b) At the request of Secured Party, upon the occurrence and during the continuance of any Event of Default, Secured Party shall be entitled to receive all distributions and payments of any nature with respect to any Pledged Collateral or instrument Collateral, and all such distributions or payments received by the Debtor shall be held in trust for Secured Party and, in accordance with Secured Party’s instructions, remitted to Secured Party or deposited to an account designated by Secured Party in the form received (with any necessary endorsements or instruments of assignment or transfer). Further, upon the occurrence and during the continuance of any Event of Default any such distributions and payments with respect to any Pledged Collateral held in any securities account shall be held and retained in such securities account, in each case as part of the Collateral hereunder, and Secured Party shall have the right to vote and to give consents, ratifications and waivers with respect to any Pledged Collateral and instruments, and to exercise all rights of conversion, exchange, subscription or any other rights, privileges or options pertaining thereto, as if Secured Party were the absolute owner thereof; provided that Secured Party shall have no duty to exercise any of the foregoing rights afforded to it and shall not be responsible to the Debtor or any other Person for any failure to do so or delay in doing so.

 

6


(c) Secured Party shall have the right to, in the name of Debtor, or in the name of Secured Party or otherwise, upon notice to but without the requirement of assent by Debtor, and Debtor hereby constitutes and appoints Secured Party (and any of Secured Party’s officers, employees or agents designated by Secured Party) as Debtor’s true and lawful attorney-in-fact, with full power and authority to: (i) sign and file any of the financing statements and other documents and instruments which must be executed or filed to perfect or continue perfected, maintain the priority of or provide notice of Secured Party’s security interest in the Collateral; (ii) assert, adjust, sue for, compromise or release any claims under any policies of insurance; (iii) give notices of control, default or exclusivity (or similar notices) under any account control agreement or similar agreement with respect to exercising control over deposit accounts or securities accounts; and (iv) execute any and all such other documents and instruments, and do any and all acts and things for and on behalf of Debtor, which Secured Party may deem reasonably necessary or advisable to maintain, protect, realize upon and preserve the Collateral and Secured Party’s security interest therein and to accomplish the purposes of this Agreement. Secured Party agrees that, except upon and during the continuance of an Event of Default, it shall not exercise the power of attorney, or any rights granted to Secured Party, pursuant to clauses (ii), (iii) and (iv). The foregoing power of attorney is coupled with an interest and irrevocable so long as the Obligations have not been paid and performed in full. Debtor hereby ratifies, to the extent permitted by law, all that Secured Party shall lawfully and in good faith do or cause to be done by virtue of and in compliance with this Section 6.

SECTION 7 Events of Default . Any of the following events shall constitute an “Event of Default”:

(a) Any “Event of Default” under the Note;

(b) Any representation or warranty by Debtor under or in connection with this Agreement shall prove to have been incorrect in any material respect when made or deemed made;

(c) Debtor shall fail to perform or observe in any material respect any other term, covenant or agreement contained in this Agreement on its part to be performed or observed and any such failure shall remain unremedied for a period of 20 days after Debtor’s knowledge thereof or notice thereof from the Secured Party; or

(d) Any levy upon, seizure or attachment of any of the Collateral which shall not have been rescinded or withdrawn.

SECTION 8 Remedies .

(a) Upon the occurrence and during the continuance of any Event of Default, Secured Party may declare any of the Obligations to be immediately due and payable and shall have, in addition to all other rights and remedies granted to it in this Agreement or the Note, all rights and remedies of a secured party under the UCC and other applicable laws. Without limiting the generality of the foregoing, (i) Secured Party may peaceably and without notice

 

7


enter any premises of Debtor, take possession of any the Collateral, remove or dispose of all or part of the Collateral on any premises of such Debtor or elsewhere, or, in the case of equipment, render it nonfunctional, and otherwise collect, receive, appropriate and realize upon all or any part of the Collateral, and demand, give receipt for, settle, renew, extend, exchange, compromise, adjust, or sue for all or any part of the Collateral, as Secured Party may determine; (ii) Secured Party may require Debtor to assemble all or any part of the Collateral and make it available to Secured Party at any place and time designated by Secured Party; (iii) Secured Party may secure the appointment of a receiver of the Collateral or any part thereof (to the extent and in the manner provided by applicable law); (iv) Secured Party may sell, resell, lease, use, assign, license, sublicense, transfer or otherwise dispose of any or all of the Collateral in its then condition or following any commercially reasonable preparation or processing (utilizing in connection therewith any of Debtor’s assets, without charge or liability to Secured Party therefor) at public or private sale, by one or more contracts, in one or more parcels, at the same or different times, for cash or credit, or for future delivery without assumption of any credit risk, all as Secured Party deems advisable; provided , however , that Debtor shall be credited with the net proceeds of sale only when such proceeds are finally collected by Secured Party. Debtor recognizes that Secured Party may be unable to make a public sale of any or all of the Pledged Collateral, by reason of prohibitions contained in applicable securities laws or otherwise, and expressly agrees that a private sale to a restricted group of purchasers for investment and not with a view to any distribution thereof shall be considered a commercially reasonable sale. Secured Party shall have the right upon any such public sale, and, to the extent permitted by law, upon any such private sale, to purchase the whole or any part of the Collateral so sold, free of any right or equity of redemption, which right or equity of redemption Debtor hereby releases, to the extent permitted by law. Secured Party shall give Debtor such notice of any private or public sales as may be required by the UCC or other applicable law.

(b) For the purpose of enabling Secured Party to exercise its rights and remedies under this Section 8 or otherwise in connection with this Agreement, Debtor hereby grants to Secured Party an irrevocable, non-exclusive and assignable license (exercisable without payment or royalty or other compensation to Debtor) to use, license or sublicense any intellectual property Collateral.

(c) Secured Party shall not have any obligation to clean up or otherwise prepare the Collateral for sale. Secured Party has no obligation to attempt to satisfy the Obligations by collecting them from any other Person liable for them, and Secured Party may release, modify or waive any Collateral provided by any other Person to secure any of the Obligations, all without affecting Secured Party’s rights against Debtor. Debtor waives any right it may have to require Secured Party to pursue any third Person for any of the Obligations. Secured Party may comply with any applicable state or federal law requirements in connection with a disposition of the Collateral and compliance will not be considered adversely to affect the commercial reasonableness of any sale of the Collateral. Secured Party may sell the Collateral without giving any warranties as to the Collateral. Secured Party may specifically disclaim any warranties of title or the like. This procedure will not be considered adversely to affect the commercial reasonableness of any sale of the Collateral. If Secured Party sells any of the Collateral upon credit, Debtor will be credited only with payments actually made by the purchaser, received by Secured Party and applied to the indebtedness of the purchaser. In the event the purchaser fails to pay for the Collateral, Secured Party may resell the Collateral and Debtor shall be credited with the proceeds of the sale.

 

8


(d) To the extent Debtor uses the proceeds of any of the Obligations to purchase Collateral, Debtor’s repayment of the Obligations shall apply on a “first-in, first-out” basis so that the portion of the Obligations used to purchase a particular item of Collateral shall be paid in the chronological order the Debtor purchased the Collateral.

(e) The cash proceeds actually received from the sale or other disposition or collection of Collateral, and any other amounts received in respect of the Collateral the application of which is not otherwise provided for herein, shall be applied first , to the payment of the reasonable costs and expenses of Secured Party in exercising or enforcing its rights hereunder and in collecting or attempting to collect any of the Collateral, and to the payment of all other amounts payable to Secured Party pursuant to Section 12 hereof; and second , to the payment of the Obligations. Any surplus thereof which exists after payment and performance in full of the Obligations shall be promptly paid over to Debtor or otherwise disposed of in accordance with the UCC or other applicable law. Debtor shall remain liable to Secured Party for any deficiency which exists after any sale or other disposition or collection of Collateral.

SECTION 9 Certain Waivers . Debtor waives, to the fullest extent permitted by law, (i) any right of redemption with respect to the Collateral, whether before or after sale hereunder, and all rights, if any, of marshalling of the Collateral or other collateral or security for the Obligations; (ii) any right to require Secured Party (A) to proceed against any Person, (B) to exhaust any other collateral or security for any of the Obligations, (C) to pursue any remedy in Secured Party’s power, or (D) to make or give any presentments, demands for performance, notices of nonperformance, protests, notices of protests or notices of dishonor in connection with any of the Collateral; and (iii) all claims, damages, and demands against Secured Party arising out of the repossession, retention, sale or application of the proceeds of any sale of the Collateral

SECTION 10 Notices . All notices or other communications hereunder shall be in writing (including by facsimile transmission or by email) and mailed (by certified or registered mail), sent or delivered to the respective parties hereto at or to their respective addresses, facsimile numbers or email addresses set forth below their names on the signature pages hereof, or at or to such other address, facsimile number or email address as shall be designated by any party in a written notice to the other parties hereto. All such notices and communications shall be effective (i) if delivered by hand, sent by certified or registered mail or sent by an overnight courier service, when received; and (ii) if sent by facsimile transmission or electronic mail, when sent. Electronic mail may be used only for routine communications, such as distribution of informational documents or documents for execution by the parties thereto, and may not be used for any other purpose.

SECTION 11 No Waiver; Cumulative Remedies . No failure on the part of Secured Party to exercise, and no delay in exercising, any right, remedy, power or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such right, remedy, power or privilege preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights and remedies under this Agreement are cumulative and not exclusive of any rights, remedies, powers and privileges that may otherwise be available to Secured Party.

 

9


SECTION 12 Costs and Expenses; Indemnification .

(a) Debtor agrees to pay on demand all costs and expenses of Secured Party, and the fees and disbursements of counsel, in connection with the enforcement or attempted enforcement of, and preservation of any rights or interests under, this Agreement and the Note, including in any out-of-court workout or other refinancing or restructuring or in any bankruptcy case, and the protection, sale or collection of, or other realization upon, any of the Collateral, including all expenses of taking, collecting, holding, sorting, handling, preparing for sale, selling, or the like, and other such expenses of sales and collections of Collateral.

(b) Debtor hereby agrees to indemnify Secured Party, any affiliate thereof, and their respective directors, officers, employees, agents, counsel and other advisors (each an “Indemnified Person”) against, and hold each of them harmless from, any and all liabilities, obligations, losses, claims, damages, penalties, actions, judgments, suits, costs, expenses or disbursements of any kind or nature whatsoever, including the reasonable fees and disbursements of counsel to an Indemnified Person, which may be imposed on or incurred by any Indemnified Person, or asserted against any Indemnified Person by any third party or by Debtor, in any way relating to or arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement or any agreement or instrument contemplated hereby, the performance by the parties hereto of their respective obligations hereunder or thereunder, the transactions contemplated hereby or the Collateral, or (ii) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by Debtor (the “Indemnified Liabilities”); provided that Debtor shall not be liable to any Indemnified Person for any portion of such Indemnified Liabilities to the extent they are found by a final decision of a court of competent jurisdiction to have resulted from such Indemnified Person’s gross negligence or willful misconduct. If and to the extent that the foregoing indemnification is for any reason held unenforceable, Debtor agrees to make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities which is permissible under applicable law.

(c) Any amounts payable to Secured Party under this Section 12 or otherwise under this Agreement if not paid upon demand shall bear interest from the date of such demand until paid in full, at the default rate of interest set forth in the Note.

SECTION 13 Binding Effect . This Agreement shall be binding upon, inure to the benefit of and be enforceable by Debtor, Secured Party and their respective successors and assigns and shall bind any Person who becomes bound as a debtor to this Agreement.

SECTION 14 Governing Law . This Agreement shall be governed by, and construed in accordance with, the law of the State of California, except as required by mandatory provisions of law and to the extent the validity or perfection of the security interests hereunder, or the remedies hereunder, in respect of any Collateral are governed by the law of a jurisdiction other than California.

 

10


SECTION 15 Submission to Jurisdiction . Debtor hereby (i) submits to the non-exclusive jurisdiction of the courts of the State of California and the Federal courts of the United States sitting in the State of California for the purpose of any action or proceeding arising out of or relating to this Agreement and any other documents and instruments relating hereto, (ii) agrees that all claims in respect of any such action or proceeding may be heard and determined in such courts, (iii) irrevocably waives (to the extent permitted by applicable law) any objection which it now or hereafter may have to the laying of venue of any such action or proceeding brought in any of the foregoing courts, and any objection on the ground that any such action or proceeding in any such court has been brought in an inconvenient forum and (iv) agrees that a final judgment in any such action or proceeding shall be conclusive and may be enforced in other jurisdictions by suit on the judgment or in any other manner permitted by law.

DEBTOR AND, BY ITS ACCEPTANCE HEREOF, SECURED PARTY, HEREBY WAIVE THEIR RESPECTIVE RIGHTS TO A TRIAL BY JURY OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING OUT OF OR RELATED TO THIS AGREEMENT. IN THE EVENT ANY LEGAL PROCEEDING IS FILED IN A COURT OF THE STATE OF CALIFORNIA (THE “COURT”) BY OR AGAINST ANY PARTY IN CONNECTION WITH ANY CONTROVERSY, DISPUTE OR CLAIM DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY (EACH, A “CLAIM”) AND THE WAIVER SET FORTH IN THE PRECEDING PARAGRAPH IS NOT ENFORCEABLE IN SUCH ACTION OR PROCEEDING, DEBTOR HEREBY AGREES, AND SECURED PARTY BY ITS ACCEPTANCE HEREOF HEREBY AGREES, AS FOLLOWS:

(1) WITH THE EXCEPTION OF THE MATTERS SPECIFIED IN SUBPARAGRAPH 2 BELOW, ANY CLAIM WILL BE RESOLVED BY A GENERAL REFERENCE PROCEEDING IN ACCORDANCE WITH THE PROVISIONS OF CALIFORNIA CODE OF CIVIL PROCEDURE SECTIONS 638 THROUGH 645.1.

(2) THE FOLLOWING MATTERS SHALL NOT BE SUBJECT TO A REFERENCE PROCEEDING: (A) NON-JUDICIAL FORECLOSURE OF ANY SECURITY INTERESTS IN REAL OR PERSONAL PROPERTY, (B) EXERCISE OF SELF-HELP REMEDIES (INCLUDING SET-OFF), (C) APPOINTMENT OF A RECEIVER AND (D) TEMPORARY, PROVISIONAL OR ANCILLARY REMEDIES (INCLUDING WRITS OF ATTACHMENT, WRITS OF POSSESSION, TEMPORARY RESTRAINING ORDERS OR PRELIMINARY INJUNCTIONS). THIS AGREEMENT DOES NOT LIMIT THE RIGHT OF ANY PARTY TO EXERCISE OR OPPOSE ANY OF THE RIGHTS AND REMEDIES DESCRIBED IN CLAUSES (A) - (D) AND ANY SUCH EXERCISE OR OPPOSITION DOES NOT WAIVE THE RIGHT OF ANY PARTY TO A REFERENCE PROCEEDING PURSUANT TO THIS AGREEMENT.

(3) UPON THE WRITTEN REQUEST OF ANY PARTY, THE PARTIES SHALL SELECT A SINGLE REFEREE, WHO SHALL BE A RETIRED JUDGE OR JUSTICE. IF THE PARTIES DO NOT AGREE UPON A REFEREE WITHIN TEN DAYS OF SUCH WRITTEN REQUEST, THEN, ANY PARTY MAY REQUEST THE COURT TO APPOINT A REFEREE PURSUANT TO CALIFORNIA CODE OF CIVIL PROCEDURE SECTION 640(B). A REQUEST FOR APPOINTMENT OF A REFEREE MAY BE HEARD ON AN EX PARTE OR EXPEDITED BASIS, AND THE PARTIES AGREE THAT IRREPARABLE HARM WOULD RESULT IF EX PARTE RELIEF IS NOT GRANTED.

 

11


(4) ALL PROCEEDINGS AND HEARINGS CONDUCTED BEFORE THE REFEREE, EXCEPT FOR TRIAL, SHALL BE CONDUCTED WITHOUT A COURT REPORTER, EXCEPT WHEN ANY PARTY SO REQUESTS, A COURT REPORTER WILL BE USED AND THE REFEREE WILL BE PROVIDED A COURTESY COPY OF THE TRANSCRIPT. THE PARTY MAKING SUCH REQUEST SHALL HAVE THE OBLIGATION TO ARRANGE FOR AND PAY COSTS OF THE COURT REPORTER, PROVIDED THAT SUCH COSTS, ALONG WITH THE REFEREE’S FEES, SHALL ULTIMATELY BE BORNE BY THE PARTY WHO DOES NOT PREVAIL, AS DETERMINED BY THE REFEREE.

(5) THE REFEREE SHALL APPLY THE RULES OF DISCOVERY AND EVIDENCE APPLICABLE TO PROCEEDINGS AT LAW IN THE STATE OF CALIFORNIA TO THE REFERENCE PROCEEDING AND SHALL DETERMINE ALL ISSUES IN ACCORDANCE WITH APPLICABLE LAW. THE REFEREE SHALL BE EMPOWERED TO ENTER EQUITABLE AS WELL AS LEGAL RELIEF AND RULE ON ANY MOTION WHICH WOULD BE AUTHORIZED IN A TRIAL, INCLUDING MOTIONS FOR DEFAULT JUDGMENT OR SUMMARY JUDGMENT. THE REFEREE SHALL REPORT HIS DECISION, WHICH REPORT SHALL ALSO INCLUDE FINDINGS OF FACT AND CONCLUSIONS OF LAW.

SECTION 16 Entire Agreement; Amendment . This Agreement contains the entire agreement of the parties with respect to the subject matter hereof and shall not be amended except by the written agreement of Debtor and the Secured Party.

SECTION 17 Severability . Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under all applicable laws and regulations. If, however, any provision of this Agreement shall be prohibited by or invalid under any such law or regulation in any jurisdiction, it shall, as to such jurisdiction, be deemed modified to conform to the minimum requirements of such law or regulation, or, if for any reason it is not deemed so modified, it shall be ineffective and invalid only to the extent of such prohibition or invalidity without affecting the remaining provisions of this Agreement, or the validity or effectiveness of such provision in any other jurisdiction.

SECTION 18 Counterparts . This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute but one and the same agreement.

SECTION 19 Termination . Upon the payment and performance in full of all Obligations in cash, the security interest created under this Agreement shall terminate and Secured Party shall, at the expense of Debtor, promptly execute and deliver to Debtor such documents and instruments reasonably requested by Debtor as shall be necessary to evidence termination of all security interests given by Debtor to Secured Party hereunder.

 

12


SECTION 20 Appointment of Secured Party .

(a) Each Investor hereby designates Ivy Investment Management Company, a Delaware corporation, as Secured Party to act as herein specified. Each Investor hereby irrevocably authorizes, and each holder of any Note by the acceptance of a Note shall be deemed irrevocably to authorize, Secured Party to take such action on its behalf under the provisions of this Agreement and the other Loan Documents and to exercise such powers and to perform such duties hereunder and thereunder as are specifically delegated to or required of Secured Party by the terms hereof and thereof and such other powers as are reasonably incidental thereto. Secured Party shall hold all Collateral and all payments of principal, interest, fees, charges and expenses received pursuant to this Agreement or any other Loan Document for the ratable benefit of the Investors except as otherwise provided herein. Secured Party may perform all or any of its duties hereunder by or through its agents, sub-agents or employees.

(b) The provisions of this Section 20(b) are solely for the benefit of Secured Party and Investors, and Debtor shall not have any rights as a third party beneficiary of any of the provisions hereof. In performing its functions and duties under this Agreement, Secured Party shall act solely as agent of Investors and does not assume and shall not be deemed to have assumed any obligation toward or relationship of agency or trust with or for Debtor.

SECTION 21 Nature of Duties of Secured Party . Secured Party shall have no duties or responsibilities except those expressly set forth in this Agreement. Neither Secured Party nor any of its officers, directors, managers, partners, trustees, advisors, auditors, employees, or agents, sub-agents, attorneys and other representatives of Secured Party and its affiliates shall be liable for any action taken or omitted by it as such hereunder or in connection herewith, unless caused by its or their gross negligence or willful misconduct. The duties of Secured Party shall be mechanical and administrative in nature; Secured Party shall not have by reason of this Agreement a fiduciary relationship in respect of any Investor; and nothing in this Agreement, expressed or implied, is intended to or shall be so construed as to impose upon Secured Party any obligations in respect of this Agreement except as expressly set forth herein.

SECTION 22 Certain Rights of Secured Party . Without limiting Secured Party’s rights and discretion under any provision hereof, Secured Party shall have the right to request instructions from the Investors. If Secured Party shall request instructions from the Investors with respect to any act or action (including the failure to act) in connection with any Loan Document, Secured Party shall be entitled to refrain from such act or taking such action unless and until Secured Party shall have received instructions from the Investors and Secured Party shall not incur liability to any Person by reason of so refraining. Without limiting the foregoing, no Investor shall have any right of action whatsoever against Secured Party as a result of Secured Party acting or refraining from acting hereunder in accordance with the instructions of the Investors, for any reason or no reason.

SECTION 23 Collateral Matters .

(a) Each Investor authorizes and directs Secured Party to accept the other Loan Documents for the benefit of Investors. Secured Party is hereby authorized, on behalf of all Investors, without the necessity of any notice to or further consent from any Investor, from time to time prior to an Event of Default, to take any action, in its sole discretion, with respect to any Collateral or Loan Document which may be necessary or appropriate to perfect and maintain perfected or enforce the Liens upon the Collateral granted pursuant to this Agreement.

 

13


(b) Investors hereby authorize Secured Party, at its option and in its discretion, to release any Lien granted to or held by Secured Party upon any Collateral (i) upon payment in immediately available funds and satisfaction of all of the Obligations at any time arising under or in respect of this Agreement or the Loan Documents or the transactions contemplated hereby or thereby, (ii) constituting property being sold or disposed of upon receipt of the proceeds of such sale by Secured Party if the sale or disposition is permitted under this Agreement or any other Loan Document or is made by Secured Party in the enforcement of its rights hereunder following the occurrence of an Event of Default or (iii) if approved, authorized or ratified in writing by the Investors.

(c) Secured Party shall have no obligation whatsoever to Investors or to any other Person to assure that the Collateral exists or is owned by Debtor or is cared for, protected or insured or that the Liens granted to Secured Party herein or pursuant hereto have been properly or sufficiently or lawfully created, perfected, protected or enforced or are entitled to any particular priority, or to exercise or to continue exercising at all or in any manner or under any duty of care, disclosure or fidelity any of the rights, authorities and powers granted or available to Secured Party in this Agreement or in any of the Loan Documents, it being understood and agreed that in respect of the Collateral, or any act, omission or event related thereto, Secured Party may act in any manner it may deem appropriate, in its sole discretion, and that Secured Party shall have no duty or liability whatsoever to Investors, except for its gross negligence or willful misconduct.

[remainder of page intentionally left blank]

 

14


IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, as of the date first above written.

 

MARRONE BIO INNOVATIONS, INC.
By      

/s/ Pamela G. Marrone

 

Name: Pamela G. Marrone

 

Title: Chief Executive Officer

Marrone Bio Innovations, Inc.

1540 Drew Ave.

Davis, CA 95618

Attn:  

Linda V. Moore, General Counsel

Fax:  

530-302-0189

email:  

lmoore@marronebio.com

 

15


IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, as of the date first above written.

 

IVY INVESTMENT MANAGEMENT COMPANY
By:  

/s/ Zachary H. Shafran

  Name:     Zachary H. Shafran
  Title:     Sr Vice President
 

Waddell & Reed

 

6300 Lamar Ave

 

Overland Park, KS 66202

  Attn:   

Cory Williams

  Fax:   

913-236-1596

  email:   

cwilliams@waddell.com

 

16


IN WITNESS WHEREOF, the parties hereto have duly executed this Agreement, as of the date first above written.

 

IVY SCIENCE & TECHNOLOGY FUND
By: Ivy Investment Management Company, its Manager
By:  

/s/ Zachary H. Shafran

  Name:     Zachary H. Shafran
  Title:     Sr Vice President
 

Waddell & Reed

 

6300 Lamar Ave

 

Overland Park, KS 66202

  Attn:   

Cory Williams

  Fax:   

913-236-1596

  email:   

cwilliams@waddell.com

 

17


WADDELL & REED ADVISORS SCIENCE & TECHNOLOGY FUND
By: Waddell & Reed Investment Management Company
By:  

/s/ Zachary H. Shafran

  Name:     Zachary H. Shafran
  Title:     Sr Vice President
 

Waddell & Reed

 

6300 Lamar Ave

 

Overland Park, KS 66202

  Attn:   

Cory Williams

  Fax:   

913-236-1596

  email:   

cwilliams@waddell.com

 

18


IVY FUNDS VIP SCIENCE & TECHNOLOGY
By: Waddell & Reed Investment Management Company
By:  

/s/ Zachary H. Shafran

  Name:     Zachary H. Shafran
  Title:     Sr Vice President
 

Waddell & Reed

 

6300 Lamar Ave

 

Overland Park, KS 66202

  Attn:   

Cory Williams

  Fax:   

913-236-1596

  email:   

cwilliams@waddell.com

 

19


SCHEDULE 1

to the Security Agreement

 

1. Jurisdiction of Organization and Organizational Identification Number

Delaware; DE; 4175693

 

2. Chief Executive Office and Principal Place of Business

1540 Drew Avenue, Davis CA 95618

 

3. Other locations where Debtor conducts business or Collateral is kept

 

Loc. #

  

Address

  

City

  

State

  

Zip Code

MBI Owned/Leased Locations

  

1

   700 Industrial Park Rd    Bangor    MI    49013

2

   1530 Drew Ave    Davis    CA    95618

3

   1540 Drew Ave    Davis    CA    95618

4

   1490 Drew Ave    Davis    CA    95618

3rd Party Warehouse locations

  

1

   5001 NW 13th Avenue B    Deerfield Beach    FL    33441

2

   3150 S. Willow Avenue    Fresno    CA    93725

3

   1211 East St. Helens    Pasco    WA    99301

4

   1000 Hanthorn Rd    Lima    OH    45804

5

   2100 Moores Lane    Mulberry    FL    33860

6

   1 N92W14350 Anthony Ave    Menomonee Falls    WI    53051

7

   5601 Anderson Rd    Tampa    FL    33614

8

   1200 Judd Ave SW    Grand Rapids    MI    49509

9

   458 West Main St    Batavia    OH    45103

10

   2801 Oak Grove Rd    Ennis    TX    75119

11

   250 Karl Clark Rd    Edmonton, AB    CAN    T6N 1E4

12

   4101 Knighthurst    Ennis    TX    75119

13

   59370 Red Arrow Hwy    Hartford    MI    59370

14

   3900 Collins Rd    Lansing    MI    48910

15

   3655 W Quail Ave #B    Las Vegas    NV    89118

16

   329 Four Mile Creek    Niagara On the Lake    ON    L0S1P0

17

   1800 W. Indiana Ave.    Philadelphia    PA    19132

18

   6143 N. 60th Street    Milwaukee    WI    53218

19

   133 E. Krauss St.    St. Louis    MO    63111

20

   41 Runway Road    Levittown    PA    19057

 

S-1


4. Deposit Accounts and Security Accounts

 

Bank

  

Description

  

Account Number

Five Star Bank

   General Checking    3201035

Five Star Bank

   Money Market    3500410

Five Star Bank

   Money Market    3501897

Five Star Bank

   Payroll    3201043

Merrill Lynch Wealth Management

      2DG-07010

The Huntington National Bank

      1041003153

Five Star Bank

   Restricted Cash - Five Star Loan    3207933

Five Star Bank

   Restricted Cash - DDA Funding    3208014

 

5. Existing Liens

See Schedule 6(iv) of the Note.

 

S-2


SCHEDULE 2

to the Security Agreement

 

1. Patents and Patent Applications .

See attached.

 

2. Copyrights (Registered and Unregistered) and Copyright Applications .

None.

 

3. Trademarks, Service Marks and Trade Names and Trademark, Service Mark and Trade Name Applications .

See attached.

 

S-3


SCHEDULE 3

to the Security Agreement

CONTROL AGREEMENTS

None.

 

S-4


SCHEDULE 4

to the Security Agreement

SUBSIDIARIES

1. Interests in each limited liability company that is a subsidiary of Debtor as follows:

 

Subsidiary    Membership Interests   

Date of Issuance of

Membership Interests

Marrone Michigan

Manufacturing, LLC

   100%    July 10, 2012

2. Interests in each general partnership, limited partnership, limited liability partnership or other partnership that is a subsidiary of Debtor as follows:

 

Subsidiary

 

  

Type of

Partnership Interest

( e.g. , general,

limited)

  

Date of Issuance

or Formation

 

  

Number of Units or

Other Ownership

Interests

 

Not applicable

        

3. Capital stock of each corporate subsidiary of Debtor, and the stock certificates with respect thereto, as follows:

 

Subsidiary   

Certificate No.

   Certificate Date   

No. and Class

of Shares

Not applicable

        

 

S-5


SCHEDULE 5

to the Security Agreement

EXCLUDED ACCOUNTS

Deposit Account #3207933 and Deposit Account #3208014, both held on deposit with Five Star Bank.

 

S-6

Exhibit 10.2

EXECUTION COPY

OMNIBUS AMENDMENT TO LOAN AGREEMENT

THIS OMNIBUS AMENDMENT TO LOAN AGREEMENT (the “ Amendment ”) is made and entered into as of August 19, 2015, by and among Marrone Bio Innovations, Inc., a Delaware corporation (the “ Company ”), and Gordon Snyder, an individual, as administrative agent for the Lenders (as defined below) (the “ Agent ”).

W HEREAS , the Company, the Agent and certain of the Lenders (as defined therein) are parties to that certain Loan Agreement dated as of October 2, 2012 (as amended by that certain Amendment and Consent dated as of April 10, 2013, the “ Deal A Loan Agreement ”), related Security Agreements (as defined in the Deal A Loan Agreement) and other agreements and documents (collectively, including the Deal A Loan Agreement and the Security Agreements, the “ Deal A Loan Documents ”).

W HEREAS , the parties to the Deal A Loan Documents wish to amend the same in order to change certain terms as set forth below;

W HEREAS , the Company and the Agent have the full right, power and authority to amend the terms of the Deal A Loan Documents and, respectively, to bind the Company and the Lenders thereto.

N OW , T HEREFORE , in consideration of these premises and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree:

 

  1. Definitions

Capitalized terms used herein without definition shall have the meanings ascribed to them in the Deal A Loan Documents.

 

  2. Amendments to Deal A Loan Agreement

 

  a. Section 1.01 of the Deal A Loan Agreement is hereby amended by changing the definition of “Initial Maturity Date” from “October    , 2015” to:

““ Initial Maturity Date ” means October 2, 2015.”

 

  b. Section 1.01 of the Deal A Loan Agreement is hereby amended by inserting the following definitions in alphabetical order:

Consent and Waiver (August 2015) ” means the consent and waiver between the Company and the Agent, dated as of August 19, 2015.

Interest Amendment Date ” means September 1, 2015.

Secured Note Financing August 2015 ” means the financing pursuant to that certain Purchase Agreement, dated on or about August 20, 2015, by and among the investors from time to time party thereto, Ivy Investment Management Company, as administrative agent and collateral agent for such investors, and the Company, and the senior secured promissory notes issued pursuant thereto, relating to loans in an aggregate amount of up to $40,000,000, as such agreement and notes are amended, restated, supplemented or otherwise modified from time to time, subject to the limitations set forth in the Consent and Waiver (August 2015).”


  c. Section 2.04 of the Deal A Loan Agreement is hereby amended and restated in its entirety as follows:

“SECTION 2.04 Interest . The Company shall pay to each Lender interest on the unpaid principal amount of the Loan made by such Lender (in each of the following cases, with such interest to be paid monthly in arrears on the last Business Day in each month), (a) from the date of such Loan until and including the Interest Amendment Date, at a rate per annum equal to 12%, (b) from and after Interest Amendment Date until and including the Applicable Maturity Date, at a rate per annum equal to 18%, After the occurrence and during the continuance of an Event of Default pursuant to Section 6.01(a) , interest on the unpaid principal balance of the Loan shall accrue until all obligations of the Company to each Lender have been paid in full, at a rate per annum equal to 18%. Provided, however, notwithstanding the foregoing, any Lender may, at its request (which request shall be communicated in writing by Lender (or the Agent on such Lender’s behalf) to the Company), defer all interest due hereunder, in which case such interest shall accrue and be paid on the Applicable Maturity Date.”

 

  d. Section 2.09(a) of the Deal A Loan Agreement is hereby amended and restated in its entirety as follows:

“(a) Optional Prepayments . The Company may prepay at any time the outstanding amount of the Loans in whole or in part without penalty or prepayment.”

 

  e. Section 5.03(a) of the Deal A Loan Agreement is hereby amended by deleting the “; and” at the end of clause (xvii) thereof, deleting the period at the end of clause (xviii) thereof and replacing it with an “; and”, and adding the following as clause (xix) thereof:

“(xix) Indebtedness owed to the investors pursuant to the Secured Note Financing August 2015.”

 

  f. Section 5.03(b) of the Deal A Loan Agreement is hereby amended by deleting the “; and” at the end of clause (xvii) thereof, deleting the period at the end of clause (xviii) thereof and replacing it with an “; and”, and adding the following as clause (xix) thereof:

“(xix) Liens securing Indebtedness under the Secured Note Financing August 2015.”

 

  3. General

The term “Agreement” as used in the Deal A Loan Agreement shall for all purposes refer to the Deal A Loan Agreement as amended by this Amendment. Except to the extent expressly revised by the terms of this Amendment, all the terms and conditions of the Deal A Loan Documents remain in full force and effect. From and after the date of this Amendment, upon the request of the Agent or the Company, the Company and the Agent (on behalf of the Lenders) shall execute and deliver such instruments, documents or other writings as may be reasonably necessary or desirable to confirm and carry out and to effectuate fully the intent and purposes of this Amendment. This Amendment shall be governed by and construed under the laws of the State of California without reference to the choice of law provisions thereof. This Amendment may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. This Amendment may be executed and delivered by facsimile and upon such delivery the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other parties. This Amendment shall be deemed a Loan Document under the Deal A Loan Agreement.

[Remainder of page intentionally left blank]


I N W ITNESS W HEREOF , the parties hereto have executed this Omnibus Amendment to Loan Agreement as of the date set forth in the first paragraph hereof.

 

COMPANY:     AGENT:

M ARRONE B IO I NNOVATIONS , I NC .,

a Delaware corporation

    G ORDON S NYDER
By:  

 /s/ Pamela G. Marrone

   

 /s/ Gordon Snyder

 

 Pamela G. Marrone

 Chief Executive Officer

   

Exhibit 10.3

EXECUTION VERSION

SEPARATION AGREEMENT

THIS SEPARATION AGREEMENT (this “ Agreement ”) is made and entered into as of August 20, 2015 between MARRONE BIO INNOVATIONS, INC., a Delaware corporation company (the “ Company ”), and JAMES IADEMARCO (the “ Executive ”).

RECITALS

A. The Company and the Executive are parties to a letter agreement dated as of December 31, 2014 (as amended through the date hereof, the “Letter Agreement”), pursuant to which the Employee is currently employed by the Company as its President and Chief Operating Officer.

B. The Company and the Executive mutually desire for the Executive to transition out of his various roles at the Company.

AGREEMENT

NOW, THEREFORE, in consideration of the premises and the mutual promises set forth in this Agreement, the Company and the Executive hereby agree as follows:

1. Definitions . Unless otherwise defined herein, the capitalized terms defined in Exhibit A shall have the meanings therein specified for all purposes of this Agreement.

2. Termination of Employment; Transition Period.

(a) The Executive hereby tenders his resignation as President and Chief Operating Officer, and from all other positions he may hold with the Company or any Subsidiary, effective as of August 31, 2015 (the “ Termination Date ”), and the Company hereby accepts such resignation effective as of the Termination Date. The parties acknowledge and agree that the Executive’s employment shall terminate on the Termination Date.

(b) From the date hereof through the Termination Date:

(i) the Executive agrees to perform such duties as may be reasonably requested by the Company in connection with his transition from the position of Chief Operating Officer of the Company; provided; that the parties acknowledge and agree that the Executive is not expected or required to come to the Company’s offices after the date hereof;

(ii) the Executive shall continue to comply with the rules, regulations, and practices as adopted or modified from time to time in the Company’s sole discretion; and

(iii) pursuant to the Letter Agreement, the Executive shall remain an at-will employee and, subject to Section 4(b) below, (i) the Company may terminate the Executive’s employment at any time, with or without cause, and (ii) the Executive may voluntarily terminate his employment at any time upon reasonable advance notice to the Company.

 

1


(c) The Executive and the Company will mutually agree to the form of press release to be issued by the Company announcing the Executive’s transition from the Company pursuant to the terms hereof.

3. Compensation and Benefits .

(a) Until the Termination Date:

(i) The Executive shall continue to receive base salary in effect as of the date hereof, payable in accordance with the Company’s standard payroll procedures; and

(ii) The Executive shall receive such other benefits as are described in the Employment Letter.

(b) Following the Termination Date, and upon the Executive’s execution on the Termination Date of the Release, the Executive shall be entitled to the following:

On or before the 15th day of each of the twelve months following the Termination Date, the Company shall pay to the Executive an amount equal to one-twelfth of his base salary. Each party hereto acknowledges and agrees that the base salary severance set forth in this Section 4(d) is intended to be exempt from Section 409A pursuant to Treasury Regulation Section 1.409A-1(b)(9)(iii); provided, that the Executive shall not be eligible for or entitled to the benefits described in clauses (i) through (ii) above, and such benefits shall be null and void ab initio , if the Executive revokes the Release pursuant to paragraph (g) thereof.

(c) Provided the Executive (or the Executive’s spouse and dependents) are eligible for and timely elect to continue health and vision insurance coverage under the Consolidated Omnibus Budget Reconciliation Act (“COBRA”) following the Termination Date and in full satisfaction of the Company’s obligation to provide the Executive with medical and dental coverage for 6 months pursuant to the Letter Agreement, the Company will timely pay the premium payments for such COBRA coverage for the Executive (and the Executive’s spouse and dependents) from the first date on which Executive loses health care and vision coverage as an employee of the Company until the earlier of: (i) the date that 6 months of premium payments have been paid by the Company, (ii) the date that the Executive (or the Executive’s spouse and dependents, as applicable) receive substantially equivalent health and vision coverage in connection with new employment, or (iii) the date that the Executive (or the Executive’s spouse and dependents, as applicable) are no longer eligible for COBRA.

(d) The Company acknowledges and agrees that the Executive will not be required to reimburse the Company for any relocation expenses previously paid by the Company to the Executive under the Letter Agreement.

(e) The Executive acknowledges and agrees that, except as expressly set forth in this Section 3, he does not have, is not eligible for or entitled to, and shall not receive (i) any other compensation or benefits (under the Letter Agreement or otherwise), including any stock

 

2


options or other equity in the Company or any Subsidiary or (iii) any further, rights, title or interest in or to (A) the Company or any Subsidiary, or (B) any of their respective businesses, properties or assets.

4. Additional Obligations

(a) The Executive acknowledges and agrees that his obligations under the Confidentiality Agreement shall continue in full force and effect, including after the Termination Date.

(b) The Executive will not, directly or indirectly, individually or in concert with others, engage in any conduct or make any statement calculated or likely to have the effect of undermining, disparaging or otherwise reflecting poorly upon the Company (or its products, business, employees, officers and directors); provided, that the Executive may give truthful testimony if properly subpoenaed to testify under oath.

(c) No executive officer of the Company shall, directly or indirectly, individually or in concert with others, engage in any conduct or make any statement, calculated or likely to have the effect of undermining, disparaging or otherwise reflecting poorly upon Executive; provided, that such individuals may give truthful testimony if properly subpoenaed to testify under oath.

(d) On the Termination Date, the Executive shall surrender to the Company the personal property of the Company in his possession or control.

(e) For a period of 90 days following the date hereof, the Executive agrees to make himself available to provide to the Company (as an independent contractor) such consulting services, if any, as may be reasonably requested by the Company pursuant to such terms and conditions as may be mutually agreed to by the Executive and the Company; provided, that either party may terminate his or its obligations under this subsection (e) at any time prior to the end of such 90-day period upon written notice to the other party.

(f) The Executive agrees to cooperate fully with the Company and its affiliates and Subsidiaries in connection with their actual or contemplated defense, prosecution, or investigation of any claim or demands by third parties, or other matters, arising from events, acts, or failures to act that occurred during the time period in which the Executive was employed by the Company. Such cooperation includes, without limitation, making himself reasonably available upon reasonable notice, without subpoena, for interviews and truthful and accurate deposition and trial testimony. The Company shall reimburse the Executive for any reasonable and documented out-of-pocket fees and expenses incurred by the Executive in connection with such cooperation.

5. Representations .

(a) The Executive represents that he has full authority to enter into this Agreement and is not under any contractual restraint which would prohibit him from satisfactorily performing his duties to the Company under this Agreement.

 

3


(b) The Executive agrees to indemnify and hold harmless the Company and each MBI Party from and against any losses, liabilities, damages or costs (including reasonable attorney’s fees) arising out of a breach of any of the representations, warranties and covenants of the Executive set forth in this Agreement.

(c) The Executive acknowledges that the Company has indicated to the Executive that he is free to seek advice from independent counsel with respect to this Agreement. The Executive has either obtained such advice or, after carefully reviewing this Agreement, has decided to forego such advice. The Executive is not relying on any representation or advice from the Company or any MBI Party regarding this Agreement, its content or effect.

6. Section 409A. Each party hereto intends that all payments made under this Agreement are exempt from the requirements of Section 409A so that none of the payments or benefits will be subject to the adverse tax penalties imposed under Section 409A, and any ambiguities herein will be interpreted to be so exempt.

7. Governing Law; Jurisdiction. This Agreement shall be governed by and construed and enforced in accordance with the internal substantive laws (and not the laws of conflicts) of the State of California. The parties agree that any dispute or disagreement which may arise under or pursuant to this Agreement or the Release or the transactions contemplated hereby or thereby may be enforceable against the parties hereto in the courts of the State of California and the Federal courts of the United States sitting in Sacramento County, State of California. For such purpose, the parties hereto hereby irrevocably submit to the nonexclusive jurisdiction of such courts, and agree that all claims in respect of this Agreement and the Release may be heard and determined in such courts.

8. Equitable Relief . The Executive acknowledges that the Company is relying for its protection upon the existence and validity of the provisions of this Agreement, that the services to be rendered by the Executive are of a special, unique and extraordinary character, and that irreparable injury will result to the Company from any violation or continuing violation of the provisions hereof for which damages may not be an adequate remedy. Accordingly, the Executive hereby agrees that in addition to the remedies available to the Company by law or under this Agreement, the Company shall be entitled to obtain such equitable relief as may be permitted by law in a court of competent jurisdiction including, without limitation, injunctive relief from any violation or continuing violation by the Executive of any term or provision of this Agreement.

9. Entire Agreement. It is understood, acknowledged and agreed that there are no oral agreements between the parties hereto or their affiliates and that this Agreement (together with the Letter Agreement and the Confidentiality Agreement) constitutes the parties’ and their affiliates’ entire agreement and supersedes and cancels any and all previous negotiations, arrangements, agreements and understandings, if any, between the parties hereto and their affiliates, and none thereof shall be used to interpret or construe this Agreement. This Agreement, and the exhibits attached hereto contain all of the terms, covenants, conditions, warranties and agreements of the parties and their affiliates, shall be considered to be the only agreement between the parties hereto and their affiliates and their respective representatives and agents with respect thereto. Except as expressly stated in this Agreement, no party or its

 

4


affiliates has made any statement or representation to the other party or its affiliates regarding any fact, which statement or representation is relied upon by the other party in entering into this Agreement. Except as expressly stated in this Agreement, in connection with the execution of this Agreement, no party to this Agreement or its affiliates has relied upon any statement, representation or promise of the other party or its affiliates not expressly contained herein.

10. Assignability .

(a) In the event the Company shall merge or consolidate with any other corporation, partnership or business entity, or all or substantially all of the Company’s business or assets shall be transferred in any manner to any other corporation, partnership or business entity, then such successor to the Company shall thereupon succeed to, and be subject to, all rights, interests, duties and obligations of, and shall thereafter be deemed for all purposes hereof to be, the “Company” under this Agreement.

(b) The rights and obligations of the Executive hereunder are personal in nature and the Executive shall not, without the written consent of the Company, assign or transfer this Agreement or any rights or obligations hereunder.

(c) Except as set forth in Section 6, nothing expressed or implied in this Agreement is intended or shall be construed to confer upon or give to any person, other than the parties to this Agreement, any right, remedy or claim under or by reason of this Agreement or of any term, covenant or condition of this Agreement.

11. Amendments; Waivers. This Agreement may be amended, modified, superseded, canceled, renewed or extended and the terms or covenants of this Agreement may be waived only by a written instrument executed by the parties to this Agreement or, in the case of a waiver, by the party waiving compliance. Any such written instrument must be approved by the Board to be effective as against the Company. The failure of any party at any time or times to require performance of any provision of this Agreement shall in no manner affect the right at a later time to enforce the same. No waiver by any party of the breach of any term or provision contained in this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such breach, or a waiver of the breach of any other term or covenant contained in this Agreement.

12. Notice . All notices, requests or consents required or permitted under this Agreement shall be made in writing and shall be given to the other parties by personal delivery, overnight air courier (with receipt signature), email, or facsimile transmission (with “answerback” confirmation of transmission), sent to such party’s addresses or telecopy numbers as are set forth below such party’s signatures to this Agreement, or such other addresses or telecopy numbers of which the parties have given notice pursuant to this Section 13. Each such notice, request or consent shall be deemed effective upon the date of actual receipt, receipt signature or confirmation of transmission, as applicable.

13. Severability . Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof, and any such prohibition or unenforceability in any jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction.

 

5


IN WITNESS WHEREOF, the parties to this Agreement have executed this Separation Agreement as of the date first above written.

 

MARRONE BIO INNOVATIONS, INC.

By:  

/s/ Pamela Marrone

  Pamela Marrone
  Chief Executive Officer

/s/ James Iademarco

JAMES IADEMARCO

 

6


EXHIBIT A

DEFINITIONS

Board ” shall mean the Company’s Board of Directors.

CEO ” shall mean the Company’s Chief Executive Officer.

Confidentiality Agreement ” shall mean Employee Confidential Information and Assignment of Inventions Agreement, dated as of January 15, 2015 between the Executive and the Company.

MBI Parties ” shall mean (i) the Company, (ii) each Subsidiary, and (ii) each of their respective current and former officers, directors, affiliates, attorneys, agents, employees and representatives.

Release ” shall mean the General Release in favor of the Company in the form attached as Exhibit B hereto.

Section 409A ” shall mean Section 409A of the Internal Revenue Code of 1986, as amended, together with the regulations and other guidance thereunder

Subsidiaries ” shall mean, collectively, (i) Marrone Michigan Manufacturing, Inc. a Delaware corporation, and (ii) any other entity in which the Company may, directly or indirectly, acquire an equity interest during the Transition Period.

Termination Date ” shall have the meaning assigned to such term in Section 2(a) hereof.

Transition Period ” shall mean the period from the date hereof through the Termination Date

 

7


EXHIBIT B

FORM OF RELEASE

(a) This release (the “Release”) is being delivered by the undersigned pursuant to the Separation Agreement between the undersigned and Marrone Bio Innovations, Inc. (the “ Company ”) dated as of August 20, 2015 (the “ Separation Agreement ”). Capitalized terms not otherwise defined in this Release shall have the meaning set forth in the Separation Agreement.

(b) The undersigned hereby releases and discharges the Company and each other MBI Party from any and all claims (including claims for equity), obligations and liabilities, whether known or unknown, at law or in equity, through the date hereof relating to or arising out of (i) the undersigned’s services to, or positions with, the Company or any Subsidiary or any of their affiliates, or (ii) the undersigned’s equity interests in the Company, including any and all claims under the Age Discrimination in Employment Act, as amended by the Older Workers Benefit Protection Act of 1990, Title VII of the Civil Rights Act of 1964, the Americans with Disabilities Act, the Employee Retirement Income Security Act of 1974, the Equal Pay Act, the Family and Medical Leave Act, and any other federal, state, or local statute, rule, regulation, ordinance, public policy, or principle of common law, including but not limited to any and all claims based upon alleged wrongful or retaliatory discharge, constructive discharge, tortious interference, negligence, intentional infliction of emotional distress, defamation, invasion of privacy, employment discrimination on any basis, harassment on any basis, retaliation on any basis, fraud, breach of express or implied contract and emotional distress, and all claims for compensatory damages, punitive damages, attorneys’ fees, salary, commissions, bonuses, expense reimbursements, severance payments, deferred compensation payments, health benefits, retirement benefits, vacation pay, holiday pay, sick pay and any other wages or monies due. Notwithstanding the foregoing, the undersigned does not waive any rights he may have to enforce the terms of the Separation Agreement.

(c) The undersigned represents and agrees that he (i) has not and will not file or initiate any legal proceedings, complaints or charges of any kind with any court or governmental or administrative agency against the Company or any one or more of the MBI Parties relating to or arising out of (X) the undersigned’s services to, or positions with, the Company or any Subsidiary or any of their affiliates, or (Y) the undersigned’s equity interests in the Company and (ii) will not participate in or accept any monies from any such action either in his individual capacity or as part of a representative or class action; provided that, (i) nothing in this Agreement prohibits you from making a good faith anonymous complaint about any MBI Parties to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General regarding alleged fraud or other violations of law as contemplated by the Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, or other similar whistleblower protection laws that provide employees the right to complain anonymously and (ii) you do not need the prior authorization of the Company to make any such reports or disclosures, and you are not required to notify the Company that you have made such reports or disclosures. The undersigned further agrees that he will not solicit, encourage, assist or cooperate in any proceedings, complaints or charges against the Company or any one or more of

 

8


the MBI Parties brought by any other person or entity unless specifically subpoenaed to appear or otherwise required by court order or in an official governmental investigation or otherwise required by law. The Company and each MBI Party shall be entitled to plead this Release as a complete defense to any claim or entitlement relating to or arising out of (X) the undersigned’s services to, or positions with, the Company or any Subsidiary or any of their affiliates, or (Y) the undersigned’s equity interests in the Company, which hereafter may be asserted by the undersigned or other persons or agencies acting on their behalf in any suit or claim against the Company or any one or more of the MBI Parties. In the event that the undersigned sues the Company or any one or more of the MBI Parties in violation of this Release, he agrees and acknowledges that he will pay such Person its litigation or arbitration costs and expenses, including reasonable attorneys’ fees, associated with his defense.

(d) The undersigned acknowledges that he is familiar with the provisions of Section 1542 of the Civil Code of the State of California, which reads as follows:

“A general release does not extend to claims which the creditor does not know or suspect to exist in his favor at the time of executing the release, which if known by him must have materially affected his settlement with the debtor.”

The undersigned hereby waives and relinquishes all rights and benefits which he may have under Section 1542 of the Civil Code of the State of California (or the law of any other state or jurisdiction to the same or similar effect) to the full extent permitted by law.

(e) The undersigned has been advised in writing to consult with an attorney concerning this Release before signing it.

(f) The undersigned has twenty-one (21) calendar days after receipt of this Release to consider its terms before signing it.

(g) The undersigned has the right to revoke this Release in full within seven (7) calendar days of executing it. Any revocation must be personally delivered or mailed to the Company (Attention, Linda Moore) and postmarked within seven (7) calendar days of the date of execution of this Release. None of the terms and provisions of this Release shall become effective or be enforceable until such revocation period has expired.

(h) Notwithstanding the foregoing, the parties acknowledge and agree that you are not waiving or being required to waive any right that cannot be waived as a matter of law, including the right to file a charge with or participate in an investigation by a governmental administrative agency; provided, however, that you hereby disclaim and waive any right to share or participate in any monetary award resulting from the prosecution of such charge or investigation.

Executed this         of August , 2015

 

 

9

Exhibit 99.1

 

LOGO

August 21, 2015

Marrone Bio Innovations Announces Completion of $40 Million Loan Financing; Update on Management and NASDAQ Matters

DAVIS, Calif., Aug. 21, 2015 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (the “Company”), (NASDAQ:MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, announced today that it has completed a $40 million loan financing.

The financing involves the Company’s issuance to the lenders of Senior Secured Promissory Notes in the aggregate principal amount of $40,000,000, accruing interest at a rate of 8% per annum, with $10 million payable 3 years from the closing, $10 million payable 4 years from the closing, and $20 million due 5 years from the closing. The Company also issued to the lenders warrants to purchase up to an aggregate of 4,000,000 shares of Common Stock at an exercise price equal to $1.91 per share (subject to certain limitations on exercisability). The Company currently intends to use the proceeds of the loan for working capital and other general corporate purposes.

Pam Marrone, Chief Executive Officer, said, “We are grateful for the support of our lenders in recognizing the long term potential of the Company.”

The Company also announced that James Iademarco, the Company’s President and Chief Operating Officer since January 2015, has elected to resign effective August 31st, 2015. To assist with the transition of various pending matters, Mr. Iademarco has agreed to remain available to advise the Company in a consulting capacity for an additional period of up to 90 days. Elin Miller, Chairman of the Board, said, “We very much appreciate James’ contributions to the Company, and we wish him the best in his future business endeavors.”

Mr. Iademarco added, “I am happy to have been able to assist the Company during a challenging period for the Company, and I am proud of our team members who have committed themselves to strengthening the Company’s business.”

The Company further announced that, as anticipated, it has received a letter from the Listing Qualifications Staff (the “Staff”) of The NASDAQ Stock Market LLC (“NASDAQ”) notifying the Company of its continued noncompliance with NASDAQ Listing Rule 5250(c)(1) as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the three months ended June 30, 2015 (the “Form 10-Q”) on August 15, 2015. As reported in the Company’s Notification of Late Filing on Form 12b-25 filed with the Securities and Exchange Commission (the “SEC”) on August 17, 2015, the Form 10-Q will not be filed with the SEC until after the completion of Company management’s evaluation of the necessity, nature and scope of any restatements to its previously filed financial statements. The Company currently expects that it will be able to file all delinquent reports, including the Form 10-Q, prior the November 9, 2015 expiration of the stay on suspension of trading granted by NASDAQ for the Company to regain compliance with NASDAQ’s filing requirement.

About Marrone Bio Innovations

Marrone Bio Innovations, Inc. (NASDAQ:MBII) is a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets. Our effective and environmentally responsible solutions help customers operate more sustainably while controlling pests, improving plant health, and increasing crop yields. We have a proprietary discovery process, a rapid development platform, and a robust pipeline of pest management and plant health product candidates. At Marrone Bio Innovations we are dedicated to pioneering better biopesticides that support a better tomorrow for users around the globe. For more information, please visit www.marronebio.com .

Forward Looking Statements

Portions of this release may constitute “forward-looking statements and assumptions underlying such forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995 (the “PSLRA”), Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Any such forward-looking statements are made within the “safe-harbor” protections of the PSLRA, should not be relied upon as representing our views as of any subsequent date, and we are under no obligation to, and expressly disclaim any responsibility to, update or alter these forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements in this release include those regarding the Company’s intended use of proceeds from the sale of notes and warrants in the financing, the


Company’s financial statements, and expectations regarding the timing of the announcement of financial results or any restatements and regaining full compliance with the NASDAQ listing requirements. Such forward-looking statements are based on information available to the Company as of the date of this release and involve a number of risks and uncertainties, some beyond its control, that could cause actual results to differ materially from those anticipated by these forward-looking statements. Such risks include that the Company may not be successful in growing sales of its products and expects intense competition in its target markets, that the Company may need to raise additional capital to meet its business requirements in the future, and the Company may not be able to do so on reasonable terms or at all, uncertainty surrounding management’s evaluation of the nature and scope of any necessary restatements to its previously filed financial statements, the types of errors and adjustments that may be required in any such restatement, cooperation of the Company’s third party distributors, potential legal or regulatory action related to the matters under investigation, and adverse decisions by the SEC or NASDAQ. Additional information that could lead to material changes in the Company’s performance is contained in its filings with the SEC.

CONTACT: Media Contact:

Cory Ziskind

ICR

646-277-1232

Cory.Ziskind@icrinc.com

 

LOGO

Source: Marrone Bio Innovations

News Provided by Acquire Media